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Abstract 
Prolonged blockade of nicotinic receptors induces sprouting of axon collaterals at the 
neuromuscular junction (Holland, R.L. and Brown, M.C., 1980). 
The present study examined the role of muscarinic receptors in the control of 
collateral sprouting in the adult hippocampus. It was hypothesised that the state of 
muscarinic receptor activation could promote plastic change at hippocampal 
cholinergic synapses. In experiment one, quinuclidinyl benzilate (QNB; 20 ~g/2 ~1), 
an irreversible muscarinic antagonist was injected unilaterally into the hippocampus of 
female Sprague Dawley rats. Beta hydroxypropylcyclodextrin (36%) served as a 
vehicle which was injected into the opposite hemisphere. Subjects were sacrificed 1, 4, 
14 or 21 days after treatment. Brain sections (40 ~m) were reacted for 
acetylcholinesterase (AChE). Increased AChE staining in the area of the injection site 
was visible at the 4 day interval in the QNB treated hippocampi. No increase in AChE 
staining was seen at the 4 day interval in vehicle treated hippocampi. Brains examined 
after a 1 day interval showed increased staining limited to the needle track in both 
vehicle and drug injected hemispheres which appeared to be a function of blood 
accumulation. At the 14 day interval staining increases were still present at the QNB 
injection site but were reduced compared to the 4 day interval. An increase in AChE 
staining was no longer evident at the QNB injection site at the 21 day interval. These 
data suggest that irreversible blockade of muscarinic receptors can induce collateral 
sprouting of AChE reactive fibers in the hippocampus. It is hypothesised that 
sprouting is rapidly induced and retraction occurs following renewed receptor 
activation. 
Experiment two assessed the effect of hemisphere, sex and drug dosage on QNB-
induced collateral sprouting in Sprague Dawley rats. Quinuclidinyl benzilate (20 ~g/~ 
~1 or 40 ~g/2 11l) was intrahippocampally injected into either right or left hemispheres 
of male and female rats. Rats were sacrificed four days following treatment and 
brains were reacted for AChE. Acetylcholinesterase positive fiber outgrowth was 
demonstrated using both QNB doses, in right and left hemispheres and in both male 
and female rats. Neither variable of experiment two effected the occurrence of AChr. 
positive collateral sprouting in the hippocampus. 
ii 
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The present study investigates a form of hippocampal plasticity that involves the 
potential of this region to physically restructure its cholinergic inputs under a situation of 
prolonged muscarinic antagonism. Prior to introducing the hypothesis and background 
information that support the predictions of the present study, a section will be dedicated 
to discussing hippocampal anatomy and the septohippocampal cholinergic tract. This will 
serve to familiarize the reader with the area of the brain under investigation in this study. 
Hippocampal anatomy and the septohippocampal track 
The hippocampus can be differentiated into distinct anatomical regions (see figure 
1). The hippocampus proper or cornu ammonis (CA) is composed of three distinct areas 
referred to as CAl, CA2 and CA3 (Swanson, Kohler and Bjorklund, 1987). These areas 
are comprised primarily of pyramidal cells. Cornu ammonis can further be subdivided 
in to strata oriens, pyramidale, radiatum and lacunosum-moleculare (Swanson et al . .' 
1987). The second major region of the hippocampus is the dentate gyrus or fascia 
dentata. This "U"-shaped structure can be divided into medial and lateral blades also 
known as infrapyramidal and suprapyramidal blades respectively (Swanson et al., 1987 
; Amaral and Witter, 1989). The dentate gyrus can be divided into three layers known 
as molecular, granular and polymorph zones. The medial and lateral blades are 
composed of a molecular layer (outer, middle, inner sublayers) containing granule cell 
dendrites that receive terminal connections from entorhinal, septal and commissural 
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Figure 1. Horizontal section through the hippocampus of the rat. 
Adapted from Swanson, Kohler and Bjorklund (1987) In Handbook of 
Chemical Neuroanatomy. (With permission trom Elsevier Science 
Publishers). 
Abbreviation•z CAl - field CAl of Ammon's horn ; CA2 - field CA2 of 
Ammon's horn ; CA3 a field CA3 of Ammon's horn ; DG (lb,mb) • 
dentate gyrus (lateral and medial blades) ; SUB • subiculum ; alv 
- alveus i fi - fimbria i gl - granule layer i hf a hippocampal 
fissure ; ml • molecular layer ; pl • polymorph or hilar layer ; sl 
• stratum lucidum , slm - stratum lacunosum-moleculare ; so -= 
stratum oriens ; sp ·~ pyra~idal layer ; sr • stratum radiatum. 
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association fibers (Swanson et al., 1987). Sensory information travels to the molecular 
layer via perforant path fibers originating in the entorhinal cortex (Amaral et al., 1989). 
A granule cell layer is surrounded by the molecular layer in the dentate gyrus. The area 
between the lateral and medial blades and extending toward the boundary of CA3, is 
referred to as the hilar region or polymorph layer and is composed of a variety of 
neuronal types (Swanson et al., 1987 ; Amaral et al., 1989). 
The cholinergic system of the brain is widespread in that it supplies acetylcholine 
(Ach) fibers to numerous regions from two major sources. Cholinergic neurons of the 
basal forebrain project to cortical regions while mesopontine tegmentum cholinergic fibers 
project mainly to the thalamus (Semba, 1990). The medial septal nucleus and the nucleus 
of the vertical limb of the diagonal band are the main sources of an extensive cholinergic 
pathway to the hippocampus that travels in the fimbria-fornix fiber bundle (Wainer, 1990 
; Semba, 1989; Amaral and Kurz, 1985 ; Lynch, Rose and Gall, 1977). This pathway 
provides 90 percent of the cholinergic innervation to areas of the hippocampus (Gage . 
Bjorklund and Stenevi, 1983). The other ten percent of cholinergic fibers arise from a 
path that innervates the ventral hippocampus after traversing the piriform lobe (Gage et 
al., 1983 ; Wainer, 1990). 
A prominent transmitter of the septohippocampal pathway is Ach (Swanson, 1977 
; Wainer, 1990). Within the regions of the hippocampus there are distinct patterns of Ach 
innervation (Swanson, Kohler and Bjorklund, 1987). Cholinergic inputs can be assessed 
by observing the number of acetylcholine binding sites in a given region using radio-
4 
ligand binding techniques or reacting tissue for biochemical markers of cholinergic 
activity (Sokolovsky, 1984). 
There are two types of cholinergic receptors - muscarinic and nicotinic (Zilles, 
1988). Of the muscarinic class, there are M1 and M2 receptor subclasses differentiated 
primarily on ligand affinities and tissue localization (Zilles, 1988). The M 1 receptors are 
thought to be postsynaptic while M2 receptors are believed to be presynaptic in nature 
(Cooper, Bloom and Roth, 1986 ; North, Slack and Surprenant, 1985). Postsynaptic 
muscarinic receptors are thought to activate physiological changes at the postsynaptic 
membrane consequent to Ach input to the hippocampus while presynaptic receptors act 
to regulate the release of Ach from cholinergic axons (Sokolovsky, 1984). The absolute 
density of M 1 binding sites exceeds that of the M2 receptor sites in the hippocampus 
(Cortes and Palacios, 1986). 
The absolute density of nicotinic receptors is much lower than the values 
of muscarinic receptors in the hippocampus (Zilles, 1988). While both pre and 
postsynaptic muscarinic receptors have been reported , the nicotinic receptor is believed 
to be presynaptic only with respect to the brain (Cheney, 1991). Conversely, nicotinic 
receptors are found postsynaptically in the peripheral nervous system (PNS) at the 
neuromuscular junction. The present study focused on antagonism of muscarinic 
receptors in the hippocampus in an attempt to elucidate information regarding their 
involvement in plastic responsiveness of cholinergic fiber inputs. Given the numerical 
dominance of postsynaptic muscarinic receptors in the hippocampus over presynaptic 
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receptor types, any manipulation of the muscarinic receptor system in the present study . 
is presumed to exert its major physiological effect at the postsynaptic region. While 
muscarinic manipulations do affect presynaptic receptors, this effect is primarily with 
respect to transmitter regulation and will have little consequence for postsynaptic receptor 
activation when the postsynaptic receptor population is antagonized as in the treatment of 
the present study. 
Swanson et al. (1987) discuss the relative densities of muscarinic receptors in the 
hippocampus. Receptor densities were determined using the labelled antagonist tritiated 
N-methyl scopolamine (NMS), a general marker of both types of muscarinic receptors 
(Swanson et al., 1987). Table 1 illustrates the relative distributions of muscarinic 
receptors in the hippocampus and compares this to acetylcholinesterase (AChE) and 
choline acetyl transferase (ChAT) densities in the same region. The highest densities of 
muscarinic receptors are found in molecular and hilar regions of the DG, strata oriens and 
radiatum of CAl and stratum oriens of CA3. Moderate levels of muscarinic receptors 
are observed in stratum pyramidale of CAl and strata radiatum and moleculare of CA3. 
The lowest relative densities of muscarinic receptors are found in the granule cell layer 
of the DG, strata lacunosum and moleculare of CAl and strata pyramidale and lucidum 
of CA3. 
The distribution of specific muscarinic receptor binding sites within the 
hippocampus varies across its anatomical regions. Research is still necessary to fully 
differentiate binding distributions of Ml and M2 muscarinic receptor subtypes (Zilles, 
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Table 1. The relative density of muscarinic recepton in different layers of hippocampal fields 
and their relationship to the relative density of known cholinergic inneMtion 
Anatomical region Cholinergic 
innervation 
Muscarinic 
([3B]NMS) 
A ebB ChAT 
DENTATE GYRUS 
molecular layer +++ ++ ++ 
granular layer + 0 0 
hilar region +++ + ++ 
AMMON'S HORN, FIFLD CAl 
stratum oriens +++ ++ ++ 
stratum pyramidale ++ +++ + + + 
stratum radiatum +++ + + 
stratum lacunosum + + ++ 
stratum moleculare + 
AMMON'S HORN, FIELD CA3 
stratum oriens +++ ++ + + + 
stratum pyramidale + +++ +++ 
stratum ludicum + + + 
stratum radiatum ++ + + 
stratum moleculare ++ ++ ++ 
SUBICULUM 
stratum pyramidale +++ ++ +++ 
stratum radiatum + + +++ ++ 
stratum moleculare • + + 
Table adapted from s~anson, Kohler and Bjorklund (1987) In. 
Handbook of Chemical Neuroanatomy. (With permission from Elsevier 
Science Publishers). 
Abbreviations: AChE = acetylcholinesterase ; ChAT = choline 
acetyltransferase ; NMS = N-methylscopolamine 
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1988). To date however, preliminary muscarinic receptor levels for Ml and M2 binding 
sites have been mapped out for the hippocampus (Zilles, 1988). The highest relative 
densities of M 1 binding sites are found in the strata pyramidale and radiatum of CA 1 and 
in stratum moleculare of the fascia dentata (Zilles, 1988). The lowest Ml binding site 
densities are found in all layers of CA2 and CA3 and in hilar fascia dentata (Zilles, 
1988). The highest density of M2 binding sites is found in stratum lucidum of CA2 and 
in stratum pyramidale of CAl and CA2 (Zilles, 1988). The lowest binding densities ot 
the M2 receptor are found in stratum lacunosum-moleculare of CAl and in stratum 
moleculare of the fascia dentata (Zilles, 1988). 
Table 1 illustrates the distributions of AChE and ChAT reactivity in the 
hippocampus. Acetylcholinesterase is an indirect marker of cholinergic innervation as it 
is an enzyme associated with Ach degradation (Cooper et al., 1986; Sokolovsky, 1984). 
Choline acetyltransferase, on the other hand is a direct marker of cholinergic neurons and 
axons and is the enzyme that catalyses the synthesis of Ach from choline (Cooper et.al .' 
(1986) ; Sokolovsky (1984)). Acetylcholinesterase distributions correlate relatively well 
with those of ChAT in the hippocampus. There is moderate AChE staining in the 
molecular layer of the DG and a similar level of ChAT activity. Choline 
acetyltransferase activity is moderate in the hilus while AChE is low in the same region . 
In theCA 1, distributions of both AChE and ChAT are similar in strata oriens, pyramidale 
and radiatum. There is a similar consistency between the two markers in CA3 with the 
exception of stratum oriens which has moderate AChE staining and high ChAT reactivity. 
8 
This comparison suggests that AChE and ChAT are similarly distributed throughout the 
hippocampus with only a few exceptions, and either marker is adequate when assessing 
cholinergic activity in that region. 
Embryonic septal cell transplants 
Recently, considerable information has been generated regarding the potential of 
the hippocampal cholinergic system to regenerate connections following their removal by 
surgical means (Dunnett, 1991 ; Bjorklund, Gage, Stenevi and Dunnett, 1983). Through 
embryonic septal cell transplant procedures neuroscientists have been able to better 
understand the plastic properties of the hippocampus. Embryonic cholinergic grafts 
placed in the hippocampus of the fimbria-fornix lesioned rat have produced both 
anatomical reinnervation and functional recovery from behavioral deficits (Bjorklund and 
Gage, 1984 ; Dunnett et al., 1991). These findings suggest that perhaps the hippocampus 
can recover from states of cholinergic depletion with the aid of tissue implants thaf 
effectively restore cholinergic input to the damaged hippocampus. 
Research is attempting to disclose the factors that can influence graft innervation 
of host tissue and subsequent viability of this input (Dunnett, Whishaw, Bunch and Fine, 
1986 ; Gage, Buzsaki and Armstrong, 1990). One focus is neurally produced nerve 
growth factor (NGF) (Gage et al., 1990). Nerve growth factor (NGF) exists in highest 
central nervous system (CNS) concentrations in the hippocampus and its activity is 
increased following fimbria-fornix lesions (Collins and Crutcher, 1985 ; Gage et al., 
9 
1990). It is thought that NGF is synthesised in the hippocampus and transported 
retrogradely to cholinergic neurons of the basal forebrain where it prevents neuronal 
degeneration following fimbria-fornix lesions (Seiler and Schwab, 1984). 
Buzsaki, Bickford, Varon, Armstrong and Gage (1987b) investigated the effects 
of NGF on host septal cells following a fimbria-fornix lesion in rats. Buzsaki et al. 
(1987b) placed fetal hippocampal grafts into the fimbria-fornix lesion cavity. These grafts 
were assumed to act as a bridge for isolated host septal cells as they extended their axons 
toward the denervated hippocampus. This technique, without NGF administration , 
consistently yields small increases in ChAT and AChE in the hippocampus. Growth of 
the host septal cells through the fetal cell bridge into the host hippocampus is limited 
presumably due to the death of host septal cells in the absence of retrogradely transported 
NGF (Buzsaki et al., 1987b). It was hypothesized that delivery of NGF to the lateral 
ventricle could promote survival and the extension of cholinergic axons to the 
hippocampus from the host septum. Buzsaki et al. (1987b) combined the transplant 
technique with infusions of NGF and measured subsequent ChAT and AChE staining in 
the hippocampus. They found that NGF administered after graft implantation lead to 
increased choline acetyltransferase immunoreactivity (Chat-IR) in host septal cells and 
increased reinnervation of the hippocampus compared to a graft plus fimbria-forn1 x 
condition alone (no NGF treatment). It appears as if NGF enhances reinnervation and 
survival of embryonic septal cell transplants. 
Neurotransmitters too can influence graft outgrowth and survival. Noradrenergic 
10 
transmitter availability within a system receiving a cholinergic septal graft influences the 
reinnervation of host tissue by that graft. Dunnett, Whishaw, Bunch and Fine ( 1986) 
assessed the survival of embryo cholinergic cell transplants to the adult rat forebrain with 
intrinsic cholinergic innervation removed through nucleus basalis lesions. They measured 
the extent of AChE innervation of the host brain by a cholinergic graft under control and 
noradrenaline depleted conditions. Nucleus basalis lesioned subjects were depleted of 
forebrain noradrenaline by 6-hydroxydopamine (6-0HDA) followed by cortically placed 
cholinergic grafts. This manipulation resulted in a significant enhancement of AChE 
positive fiber outgrowth relative to an intact noradrenergic system control condition. This 
suggests that neurotransmitter influences also play a role in regulating plastic change in 
the CNS. 
Sprouting 
When discussing forms of hippocampal plasticity and the factors that promote 
regeneration of cholinergic system communication within the hippocampus, sprouting 
research can provide some valuable insight. Injury of brain regions can induce a trophic 
signal that results in a level of recovery that can be physically measured. Terminal 
sprouting or reactive synaptogenesis, in response to a lesion has been reported in the CNS 
(Cotman and Nieto-Sampedro, 1984). This sort of central sprouting differs from the 
widely studied PNS sprouting in that growth distances are usually shorter, less than 50 
to 100 micrometers (~m) (Gage et al., 1983). The onset of CNS terminal sprouting 
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responses are quick. The initiation of terminal sprouting in the CNS requires one to five 
days in the adult (Cotman et al., 1984 ; Gage et al., 1983). During reactive 
synaptogenesis, reinnervated areas are restricted to regions of sprouting terminals. It is 
this form of sprouting that is believed to immediately follow the infliction of injury upon 
a system. Two to four days after lesioning the perforant pathway, reactive synaptogenesis 
can be observed in the molecular layer of the dentate gyrus (Cotman et al., 1984). 
Levels of the synaptic growth associated phosphoprotein (GAP-43), a marker of 
developing axons, increase within the molecular layer after such a lesion and are 
indicative of axon terminal outgrowth (Benowitz, Rodriguez and Neve, 1990). 
Other forms of sprouting require more time before reinnervation is seen and thus 
do not fall into the same class as reactive synaptogenesis (Gage et al., 1983). An 
example is compensatory collateral sprouting which requires one to three months before 
' 
regeneration of fibers is noted. This time difference is primarily due to the distance 
across which fibers must travel to effect reinnervation. Compensatory collateral sprouting 
is not simply terminal in nature as with reactive synaptogenesis but involves a rerouting 
of fibers of a given intact system to reinnervate a denervated system. For example, Gage 
et al., (1983) demonstrated that cholinergic fibers innervating ventral hippocampus can 
sprout to dorsal sites where they replace denervated dorsal cholinergic inputs. The 
response was elicited by lesioning the fimbria-fornix tract of rats. One to two weeks 
following the lesion ChAT levels were reduced by 95 percent in dorsal hippocampus. 
One to three months after the lesion there was up to 40 percent recovery of ChAT levels. 
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The lengthened time course relative to reactive synaptogenesis can be understood given 
that fibers from ventral hippocampus had to traverse a distance of three to four 
millimeters (mm) to reach dorsal hippocampus. 
Acetylcholinesterase as a marker of cholinergic fiber 
outgrowth 
Acetylcholinesterase activity is widely used to assess sprouting within the 
hippocampus (Gage et al., 1983 ; Lynch, Matthews, Mosko, Parks and Cotman, 1972 
; Storm-Mathisen, 1974 ; Nadler, Cotman and Lynch, 1977 ; Nadler, Cotman, Paoletti 
and Lynch, 1977 ; Steward and Messenheimer, 1978 ; Amaral, Avendano and Cowan, 
1980 ; Scheff, Benardo and Cotman, 1980; Stanfield and Cowan, 1982 ; Woodruff and 
Baisen, 1990 ; McKeon, Vietje and Wells, 1989). For example, the hippocampu~ 
receives afferents from the septum, subicular and entorhinal cortices. If the entorhinal 
cortex is lesioned electrolytically, an intense band of AChE reactivity appears in the outer 
part of the molecular layer of the dentate gyrus. If the septum is lesioned at the time of 
an entorhinal lesion, no stain increases are seen (Lynch et al., 1972). The study of 
Lynch et al., (1972) suggests that septal neurons sprout into the outer molecular layer of 
rats following entorhinal lesions and that this response can be measured by increases m 
AChE staining (Lynch et al., 1972). 
Stanfield and Cowan (1982) also investigated the effects of unilateral entorhinal 
cortex lesions on AChE staining in the molecular layer of the DG. Entorhinal lesions 
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produced an intensification of AChE stain in the molecular layer of rats when conducted 
four to six weeks prior to sacrificing the subjects. Septal fibers were believed to be the 
source of the AChE positive intensification seen in that study (Stanfield and Cowan, 
1982). 
Woodruff et al. (1990) employed the neurotoxin trimethyltin chloride (TMT) and 
produced massive cell loss in the entorhinal cortex. Orally administered TMT effectively 
lesions the entorhinal cortex input to the hippocampus (Woodruff et al., 1990). 
Administration of TMT resulted in significantly denser AChE staining in the dentate 
molecular layer relative to control subjects. Woodruff et al. (1990) concluded that the 
increased AChE staining is the result of sprouting septal axon terminals into the zone 
denervated by the entorhinal cortex lesion. 
Acetylcholinesterase activity is also a widely used marker of cholinergic transplant. 
growth (Dunnett, Low, Stenevi and Bjorklund, 1982 ; Dunnett et al., 1986 ; Bjorklund 
et al., 1983). Embryo septal cells implanted into a damaged septohippocampal system 
reinnervate host tissue over approximately one to six months. The amount of 
reinnervation has been assessed by the levels of AChE staining in the hippocampus. As 
the donor cholinergic fibers grow into host tissue, AChE staining increases indicating 
restoration of cholinergic innervation of the hippocampus (Dunnett, 1991 ; Dunnett et al., 
1982; Bjorklundetal., 1983). 
In the present study, AChE staining will be used to assess the level of cholinergic 
fiber terminal sprouting following prolonged muscarinic receptor antagonism. 
14 
Acetylcholinesterase staining has served as a reliable marker of cholinergic fiber 
outgrowth in both sprouting and transplant paradigms and is therefore a logical and 
straight forward system for use in evaluating the effectiveness of the novel technique used 
in the present study to induce sprouting. 
Hypothesis 
Both transplantation and sprouting paradigms are focusing on the elucidation of 
the stimuli necessary for hippocampal plastic responsiveness to injury (Dunnett et al., 
1986 ; Gage et al., 1990). In the case of tissue transplantation, fiber outgrowth has an 
upper limit with respect to the extent of host reinnervation. This upper limit seems to be 
attained after approximately six months (Dunnett et al., 1986; Bjorklund et al., 1983). 
One focus of research in this instance should be on increasing the amount of host tissue 
reinnervation. The isolation of stimuli that are capable of expediting graft outgrowth , 
would be an asset to therapeutic advances in combating diseases of the cholinergic 
system. 
This present proposal is an attempt to isolate one potential stimulus that could 
influence growth and repair in the CNS. This hypothesis is based on the concept of a 
post to presynaptic communication network that regulates axonal growth, as in the case 
of sprouting, and which can be directly manipulated by varying postsynaptic receptor 
activation. That is, it is hypothesised that postsynaptic receptor antagonism will result 
in the production of a growth signal that will induce postsynaptically directed growth of 
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presynaptic axons. In the context of lesion studies, it is hypothesised that postsynaptic 
receptor antagonism will mimic partial deafferentation and cause terminal sprouting of 
cholinergic fibers. This is conceivable given that the inhibition of normal transmitter-
receptor interactions in situations of postsynaptic blockade are the same as those observed 
in states of partial denervation. In this way antagonism is a means of testing the 
hypothesis that receptor inactivity is a specific trigger of trophic agent release. 
Support of hypothesis from PNS work 
A similar approach to that taken in the present study has been employed in the 
PNS. Holland and Brown (1980) antagonized neuromuscular transmission in mice using 
repeated injections of the irreversible nicotinic blocker alpha-bungarotoxin. Repeated 
intramuscular injections were required with their "purified" sample of the irreversible 
drug because injections with a "pure" commercial sample resulted in receptor death 
(Holland et al., 1980). Doses consisted of a one microgram injection daily or two 0.5 
microgram administrations daily. Four to eight days following initiation of injections 
Holland et al. ( 1980) assessed the level of sprouting that occurred. Motor nerve 
sprouting occurred within a few days of blockade such that presynaptic terminals 
demonstrated extensive sprouting at antagonized endplates. The conclusion reached 
suggested a role for inactive postsynaptic muscle fibers in producing terminal sprouting. 
This result was exciting because it was preceded by a couple of failed attempts. Pestronk 
and Drachman (1978) delivered alpha-bungarotoxin to a muscle paralysed by botulinum, 
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an antagonist of presynaptic transmission, and reported an inhibition of the previously 
studied botulinum induced sprouting (Duchen and Strich, 1968). In this case it was 
expected that sprouting would have occurred in the situation of combined botulinum and 
nicotinic receptor blockade given that each stimulus on its own is capable of inducing a 
sprouting response (Holland et al., 1980 ; Tonge, 1974 ; Duchen and Strich, 1968). 
Tonge (1978) investigated the effect of prolonged blockade of neuromuscular transmission 
on muscle endplates. Doses of the neurotoxin of Naja siamenis venom were delivered 
to soleus muscle of mice to produce a prolonged blockade of nicotinic Ach receptors. 
Nerve sprouting was not observed in this experiment. Neuromuscular transmission was 
only inhibited for two to three days. This limited duration of receptor blockade may have 
been the reason for the result obtained. If transmission could have been antagonized 
longer, sprouting may have been seen. Unfortunately multiple doses could not be given 
due to the fact that they induce excessive muscle damage (Tonge, 1978). 
Holland et al., ( 1980) suggest that muscle inactivity, created by acetylcholine 
receptor blockade, is responsible for sprouting at the muscle end plate. However, these 
researchers further suggest that they cannot rule out a role for available acetylcholine 
(Ach) receptors. They pointed out that a single or twice daily dose of alpha-bungarotoxin 
is probably not sufficient to bind to all extrajunctional receptors. This suggests, in light 
of their clear sprouting result, that they presuppose that available Ach receptors could be 
of potential importance to trophic regulation, and the sprouting response seen in their 
study. This suggestion was first forwarded by Pestronk et al., ( 1978) who found that 
17 
nicotinic antagonism with alpha bungarotoxin inhibits the sprouting normally produced 
by botulinum toxin. Pestronk et al., (1978) argue for a role of availabe Ach receptors 
in sprouting regulation given that their combined botulinum/alpha bungarotoxin treatment 
failed to elicit sprouting as would have occurred in the botulinum condition alone; a 
condition in which Ach release is blocked but postsynaptic Ach receptors are not. The 
finding of Holland et al. (1980) clearly challenges this idea. In the context of the present 
proposal, perhaps the antagonism of Ach receptors and not the availability of these 
receptors to Ach activation is the key to the elicitation of sprouting. This approach 
toward sprouting is in line with that taken by Holland et al. (1980) in the PNS with the 
exception that muscarinic blockade in the hippocampus will not leave the postsynaptic 
cells inactive. During CNS muscarinic receptor antagonism, other neurotransmitter 
systems will remain intact. When nicotinic receptors are antagonized at the 
neuromuscular junction, as in the Holland et al. (1980) study, the post synaptic muscle 
is inactive. 
It is predicted m the present study that, in the CNS, antagonized muscarinic 
receptor populations will induce a trophic signal to presynaptic axons initiating 
presynaptic growth to antagonized regions postsynaptically as was found in the PNS by 
Holland et al., (1980). The observation of sprouting in the undamaged hippocampus, as 
triggered in this way would be supportive of the present hypothesis that prolonged Ach 
receptor inactivity, through antagonism, is a factor that can initiate cholinergic fiber 
outgrowth. That is, muscarinic receptor antagonism alone will induce growth as opposed 
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to possibly enhancing growth following its induction by other means such as by signals 
consequent to embryonic septal cell implantation. Specifically, this study will investigate 
the existence of a potentially new stimulus of sprouting within the undamaged adult 
hippocampus. The present study will, in this way, contribute to knowledge concerning 
the origin of trophic signalling necessary to initiate sprouting in stable systems such as 
the hippocampus of adult rats. 
Postsynaptic hippocampal Ach receptors 
In the PNS, Holland et al. ( 1980) blocked postsynaptic nicotinic receptors using 
alpha-bungarotoxin and induced sprouting of axons. In the present study muscarinic 
receptors have been chosen as the target of antagonism. Of the two types of Ach 
receptors, muscarinic classes are in greater abundance in the hippocampus (Zilles, 1988). 
This characteristic makes them more easily accessible to pharmacological manipulations 
such that more muscarinic receptors could be targeted in a given area than possible with' 
nicotinic receptors. Nicotinic receptors are believed to reside predominantly in 
presynaptic locations within the hippocampus and thus would not serve as an appropriate 
target for testing the present hypothesis that postsynaptic blockade can induce trophic 
signalling and subsequent presynaptic sprouting (Cheney, 1991). 
Prolonged muscarinic receptor antagonism 
The hypothesis regarding the induction of sprouting by muscarinic antagonism can 
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only be tested under a condition of prolonged blockade. If sprouting is to be induced by 
some trophic signal elicited through muscarinic blockade then the growth signal will have 
to be present long enough to elicit sprouting of presynaptic terminals. Trophic regulation 
by this means can only be maintained if the trigger, postsynaptic muscarinic receptor 
blockade, is persistent. The irreversible muscarinic receptor antagonist quinuclidinyl 
benzilate (QNB) was utilized to provide the necessary prolonged block of muscarinic 
receptors in this study. 
A factor influencing the duration of muscarinic receptor blockade is the rate of 
muscarinic receptor turnover. A given receptor may only be antagonized for the length 
of time its in existence. Once the muscarinic antagonist is placed in the brain the limiting 
factor determining duration of action will be receptor turnover. 
Sethy and Hyslop (1990) targeted muscarinic receptors using the irreversible 
muscarinic agonist BM -123. Oxotremorine, a muscarinic agonist, has been found to 
reduce the amount of Ach released at junctions in both central and peripheral nervous' 
systems (Sethy and Hyslop, 1990). When BM-123 is administered, oxotremorine is not 
effective in reducing Ach release as determined by [3H] Ach release patterns. This is due 
to the unavailability of muscarinic receptors during the irreversible BM-123 block of 
existing receptor populations. The oxotremorine induced inhibition of Ach returns to 
normal by 144 hours after the initiation of the irreversible BM-123 blockade. The 
receptors that BM-123 bound to in the Sethy and Hyslop (1990) study, are the same ones 
that QNB bind. BM-123 blockade will also prevent QNB from acting at its receptor site 
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for approximately 144 hours (Russell, Smith, Booth, Jenden and Waite, 1986). This 
suggests that muscarinic receptors turnover in significant numbers in no more than six 
days. Given this rate of receptor turnover one can expect to maintain an effective 
muscarinic block using QNB for a maximum of six days, a sufficient time to induce 
sprouting in the CNS (Storm-Mathisen, 1974 ; Cotman et al., 1982 ; Mckeon et al., 1989 
; Gage et al., 1983 ; Benowitz et al. , 1990). 
Experiment 1 
It is predicted in the following experiment that hippocampal injections of the 
irreversible muscarinic antagonist QNB will elicit sprouting, as indicated by an increase 
in AChE staining near the site of injection. Brain regions receiving a vehicle injection 
only should exhibit no sprouting of AChE positive fibers. It is further hypothesised that 
sprouting will occur given sufficient time. Animals will be assessed for AChE stain 
increases at four times: one, four, 14 and 21 days after QNB injection. It is expected ,' 
based on the rate of receptor turnover, that the antagonist should act at a receptor site for 
no more than six days (Sethy and Hyslop, 1990 ; Russell et al., 1986). Animals allowed 
to survive for a four day period should demonstrate sprouting while animals surviving for 
one day might not exhibit antagonist induced sprouting of AChE positive fibers unless the 
response is very rapid. Animals permitted to survive for 14 days may exhibit increased 
AChE staining but not to the degree of four day animals given the predicted termination 
of the sprouting signal after a maximum of six days. By 14 days it is expected that some 
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degree of retraction of sprouted fibers will occur given the absence of the muscarinic 
antagonism induced trophic signal following receptor turnover. By 21 days post 
injection, animals may not exhibit any AChE stain increases as a result of the treatment. 
Quinuclidinyl benzilate will not be bound to muscarinic receptors to maintain a sprouting 
stimulus by 21 days and sprouted fibers may retract or degenerate when the sprouting 
stimulus is terminated. 
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EXPERIMENT 1 
METHOD 
Subjects: The subjects used in the present study were 43 female Sprague 
Dawley rats weighing between 200 and 240 grams at experimental onset. All rats were 
obtained from Charles River Laboratories (Montreal, Quebec). They were housed 
individually in Plexiglas and wire cages with ad lib food and water administration. The 
housing area was maintained at a 12 hour on, 12 hour off light cycle. 
Drug treatment: The muscarinic antagonist quinuclidinyl benzilate (QNB) was used 
to induce a prolonged blockade of muscarinic receptors in this study. This drug was 
purchased from Research Biochemicals Incorporated. Quantities of QNB were dissolved 
in a beta hydroxipropylcyclodextrin (36.6%) vehicle and stored at 4 degrees Celsius to 
maintain stability. Drug stability was estimated to be 48 hours based on the advice of the 
experts at Research Biochemicals incorporated (personal communication, 1990). 
No in vivo studies utilizing QNB have been reported in the literature, so an 
effective dose could not be determined through this means. Ben-Barak and Dudai (1971.}) 
offer some indication of a possible effective QNB dose. They assessed the specific 
binding of [3H]QNB to homogenate of rat brain hippocampal formation. They found that 
saturation was reached at [3H]QNB concentrations of one to two nanomoles (nM) and that 
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similar amounts (1 nM) of atropine were required to displace the QNB. From this •t 
seems that similar concentrations of atropine and QNB would be required to saturate the 
hippocampal region. The molecular weights of the two compounds are similar as well. 
Atropine has a molecular weight of289.38 while the molecular weight of QNB is 337.38. 
Therefore, a study which utilizes intrahippocampal atropine administration would provide 
information as to an adequate QNB dose. Such a study was conducted by Leaton and 
Rech (1972) who found that locomotor activity of rats increased when given bilateral 
intrahippocampal atropine. The mode of atropine administration in this study consisted 
of tamping a cannula in the crystallized drug I 00 times and then inserting this into an 
outer cannula. It was estimated, using a weight by difference technique, that doses 
ranged from 6 ~g to 18 ~g of the drug. 
A dose of five ~g of atropine administered bilaterally in the hippocampus in a 
study by Singh, Ott and Matthies (1974) was sufficient to impair acquisition of a 'Y ' 
maze task. A drug effect was evident in their study and serves the purpose of offering 
a possible dose for use in the present study where an effective antagonizing dose is aJI 
that is required. 
From the above mentioned studies an injection of between ten and 20 ~g of QNB 
seemed a good starting point for the present study. To prepare a drug solution, QNB was 
mixed with the appropriate amount of vehicle and sonicated in a Bransonic 12 sonicator. 
This device used ultrasonic waves to break down the QNB solid into the finest particles 
possible. This produced a fine suspension. 
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The above calculated quantity of QNB (20 IJg) was employed in a pilot study prior 
to this main study in two, one and 0.5 microliter (IJI) volumes to determine the 
importance of volume for producing the hypothesised effect. The 20 IJg/2 1Jl dose was 
most effective in a study in which AChE staining was measured 14 days following a QNB 
injection into one hemisphere and a beta hydroxipropylcyclodextrin (2 IJI) vehicle into the 
other. Quinuclidinyl benzilate-injected hemispheres demonstrated increased AChE 
positive staining relative to their control, vehicle injected counterparts. These findings 
indicated that QNB (20 IJg/2 1Jl) was sufficient to cause an increase in AChE positive 
staining at the region of injection in experimental hemispheres relative to controls. Based 
on this finding, it was decided to continue with this main study employing a 20 IJg QNB 
dose in a 2 1Jl volume of vehicle. Equal volumes of vehicle were administered for 
control injections. 
Procedure: All subjects received bilateral surgical injections into their hippocampt. 
Either the right or left hemisphere received QNB (20 IJg/2 1Jl) while the other control 
hemisphere received an equal volume of 36.6% beta hydroxipropylcyclodextrin 
Injections were administered during a stereotaxic surgical procedure during which animals 
were anaesthetized with Avertin (1 cc/kg). Aseptic techniques were followed throughout 
the surgeries. Prior to drawing any QNB from the drug-containing vial, the vial and 
contents were vigorously shaken manually to ensure that the drug was evenly suspended . 
Injections were delivered using a Hamilton microliter syringe mounted on the arm of a 
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stereotaxic apparatus. Surgical incisions were made into the skin above the skull of 
subjects using a scalpel blade, their skulls were drilled above the site of injection, the 
dura lining punctured using a fine needle and the syringe containing vehicle or QNB 
positioned. The syringe contents were delivered to a site -3.8 mm posterior, +I- 3. 7 mm 
lateral and -3.7 mm ventral to bregma with the skull surface level. To prevent 
hippocampal tissue damage due to a high pressured injection of 2 ~1 volumes, injections 
lasted four minutes. The syringe plunger was lightly turned clockwise with a slight 
downward pressure for a duration of two minutes until all contents were in the 
hippocampus. Following this, the syringe was left in place for a further two minutes 
before it was removed from the brain slowly to prevent the injected substance from being 
extracted in a vacuum by a fast upward motion of the needle. Upon completion of 
injections to both sides of the brain, incisions were stapled closed with wound clips anq 
a small amount of sulphur flowers antibiotic (powder) was applied to prevent infection . 
Subjects were returned to their cages after surgery to recover. 
During the post surgical period, subjects remained in their cages until they were 
sacrificed. The rats were sacrificed at either one, four, 14 or 21 days post surgery and 
the amount of sprouting assessed, using AChE staining as the dependent measure, 
between control and experimental hemispheres. At one of the four sacrifice times, 
subjects were treated with lethal intraperitoneal injections of sodium pentobarbital 
anaesthetic (1 cc at 65 mg per rat), then perfused through the left ventricle with 30 ml 
of 0.9% phosphate buffered saline. Tissue fixation was carried out using 300 ml of 4% 
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paraformaldehyde over approximately 15 minutes. Decapitation followed the chemical 
fixation procedure. The brain was subsequently removed from the skull and stored in 4% 
paraformaldehyde overnight at 4 degrees Celsius. The next day, brains were transferred 
to a cryoprotective solution of 25% sucrose and allowed to sink at a temperature of 4 
degrees Celsius. After the brains sank they were frozen in a solution of 2-Methy1butane 
contained in a 500 ml beaker immersed in liquid nitrogen. Frozen brains were then 
sectioned using a cryostat microtome at -18 degrees Celsius. Coronal sections through 
the hippocampus were collected at a thickness of 40 IJm and mounted on chrome alum 
coated slides for further processing. 
Histochemistry: Once mounted on slides, the tissue sections were histochemically 
reacted using a stain for AChE. The tissue was incubated overnight in 200 ml of a stock 
solution of 50 mM sodium acetate, 4.0 mM copper sulphate crystals and 16 mM glycine 
set to a pH of 5.0. To this was added 0.006 g ethopropazine (inhibitor of nonspecific 
esterases) and 0.232 g acetylthiocholine iodide. The following day sections were rinsed 
six times in distilled water and developed for two minutes in a solution of 10% potassium 
ferricyanide, again rinsed three times in distilled water and reacted for one minute in a 
1% silver nitrate solution before being rinsed six more times in distilled water. Sections 
were dehydrated in two baths of acetone for ten and 30 seconds respectively then placed 
in two fresh clearing baths of xylene for 60 seconds each to remove excess acetone from 
the tissue. Sections remained in the final xylene bath while being coverslipped using 
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Mikro kit transparent coverslipping medium. 
Analysis: Comparisons of brains between experimental and control 
hemispheres were made regarding the level of AChE staining. Staining densities were 
assessed as one dependent measure in this study. These measurements were obtained 
using MCID, a computerized image analysis system (Imaging Research Inc., St. 
Catherine's, Ontario). Dimensional analysis using a Bausch and Lomb slide projector and 
a ruled scale made by Imaging Research Incorporated were also conducted for inclusion 
in the results. This involved obtaining a length measure (anterior to posterior plane) of 
stain increase throughout the hippocampus plus depth (dorsal to ventral plane) and width 
(medial to lateral plane) measures of staining at the darkest region of increase. The area 
demonstrating the greatest density of reaction was used because it best exemplified the 
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reaction, in a given subject, to the treatment. The assessment of staining was carried out 
as follows: 
1. Visual analysis: Sections from each animal were first inspected using the slide 
projector. The injection sites for each hemisphere were located and recorded in a paper 
trace of the tissue. If a stain difference between hemispheres existed the location of such 
was also recorded. If no clear injection sites or tracks were visible reaching the 
hippocampus the animal was categorized as questionable. 
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2. Density Analysis: If a stain difference existed between experimental and contrul 
hemispheres the density of the darkest region of difference was compared to equivalent 
regions in the opposite hemisphere. If sections were symmetrical on a given slide then 
this comparison was performed on the same tissue section. If however asymmetry of 
approximately greater than 0.5 mm existed within a tissue section on a given slide then 
symmetrical matches for sites being assessed were located from other sections and used 
for comparison. This procedure resulted in four relative optical density (ROD) values per 
subject as follows: 
1. A QNB injection density value (density at a site of stain increase in the QNB 
injected hemisphere), 
2. A symmetrically corresponding QNB control density value (density at a locatiun 
in the vehicle hemisphere corresponding to the area measured in the QNB hemisphere), 
3. A vehicle injection density value (density at the vehicle injection site), and 
4. A symmetrically corresponding vehicle control density value (density at a 
location in the QNB treated hemisphere corresponding to the area measured in the veh iL le 
injected hemisphere). 
The comparisons were made using ROD as the dependent measure. Relative 
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optical density measurements were obtained by placing a computer generated cursor 
window over a site being assessed and allowing the computer to calculate a ROD reading. 
The same was then done for the symmetrically corresponding section of the opposite 
hemisphere using the same shaped window at the same location. The values obtained for 
each hemisphere were then normalized into a ratio format using the ROD of the corpus 
callosum (CC) as the denominator. This normalized value allowed a between subject 
comparison to be made by taking into account the baseline tissue density differences 
between subjects. The density at the CC varies slightly between animals reflecting 
baseline density differences. When this value is divided into hippocampal stain density 
values the result is a value reflective of AChE staining density with baseline intensity 
differences accounted for. Any baseline staining intensity differences (an unavoidable 
occurrence) between animals prevent raw ROD values from being comparable. 
Normalized values account for background tissue density and can therefore be compared 
between animals with differing levels of baseline densities. 
Reporting density results: 
DESCRIPTIVE STATISTICS: The normalized ROD scores of all animals of a given 
group were averaged and this mean score as well as a standard deviation and range are 
reported in the results. Graphical illustrations of group ROD means will include standard 
error bars. 
ROD SAMPLES AS A PERCENT OF CONTROLS: 
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Analysis of animals included 
calculating normalized ROD values for each subject's vehicle and drug injected 
hemispheres at the site of AChE increase if one existed. These values were compared 
with respective normalized ROD values of the symmetrical control sample contralateral 
to the injection. The mean normalized ROD scores of QNB and vehicle injection samples 
were reported as a percentage of the respective corresponding control ROD values. 
In the case that no AChE stain differences between QNB and vehicle-injected 
hemispheres existed then ROD measures were taken at the injection sites. As per analysis 
of regions of staining increase, symmetrical sections were compared. If the injection site 
of a given hemisphere did not have a corresponding, symmetrical injection site in the 
opposite side on the same section then the corresponding symmetrical section was located 
and used for comparison. The same was then done for the vehicle injection site of the 
other hemisphere. 
3. DIMENSIONAL ANALYSIS: The size of a stain increase was measured if one 
existed. That is, the extent of a the stain increase was measured both within and between 
sections. 
A. length measure: The length (anterior to posterior plane) of stain increases in a 
hemisphere was measured and reported in millimeters (mm). This was done by counting 
the number of sections in which the stain difference persisted and multiplying by 40 ~m, 
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the thickness of each section. This was the form of the between section measure. If no 
stain differences were observed, then of course subjects were not included on this 
measure. 
B. Depth and Width Measure: The within section measure was calculated at the site 
judged to possess the greatest stain increase. The depth (dorsal to ventral plane) and 
width (medial to lateral plane) of the stained region was measured under a microscope 
slide projector using a linear scale. As with the length measure, if no stain differences 
existed between control and experimental hemispheres, then the subject in question was 
not included on this measure. 
4.Injection/Stain Correlation: The location of any stain increase was correlated with 
the injection site of a given hemisphere. If the injection site was found on the same 
section as the greatest stain increase this was recorded. If the injection site was not 
located on the same section as the greatest stain increase then the distance between the 
injection site and stain increase was recorded. 
5 .STATISTICS: Statistical analysis was carried out using an SPSS-X statistical 
software package contained on the mainframe computer of Memorial University of 
Newfoundland. Student t-tests for dependent measures were performed on pooled control 
and vehicle injection sample ROD data to determine if differences existed between control 
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and vehicle injection measures. A between group analysis of ROD measures was 
conducted using the ANOV A and assessed QNB and vehicle injection sample scores by 
group (survival time) to determine if ROD measures of QNB and vehicle injection 
samples varied by group. This analysis was followed by post hoc comparisons of mean 
group ROD measures using the Tukey test. A MANOV A was used to calculate whether 
differences existed between the groups with respect to QNB and vehicle sample ROD 
scores, and hemisphere of treatment. 
A within group analysis was computed in which each group was assessed 
individually using student t-tests that evaluated QNB injection versus vehicle injection 
sample ROD values. This set of tests was used to assess the extent of any difference 
existing within groups on experimental and control injection ROD measures. T h e 
results section of experiment one that immediately follow-s this methods section will deal 
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with the results found in each individual group (four survival times) separately and will 
primarily focus on descriptive statistics as a tool to represent the findings. The resul ts 
of the statistical analyses of experiment one will be found in the "summary results" 
section following the results of experiment two. This section will summarize the effects 
seen in both experiments one and two of the present study by presenting between and 
within group comparisons that characterize the phenomenon under study. 
6. PHOTOMICROGRAPHS: A Wild Heerbrugg Photomicroscope M400 was employed 
to magnify and photograph sections. A Wild Leitz MPS46 Photoautomat was used to 
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regulate shutter speed of the 35mm camera accompanying the M400. Kodak T-Max 100 
black and white film was used to capture section images. 
INTRODUCTION TO RESULTS. 
The results section of the present experiment set will describe observations made 
in the one, four, fourteen and twenty-one day survival groups in that order. Due to the 
fact that this study utilizes a novel approach to CNS sprouting, it was decided to format 
the results in such a way that they are descriptive in nature. This approach is considered 
appropriate when reporting findings gathered through a set of pilot experiments as is the 
case here. Result reporting for the respective groups will consist of a general statement 
about the results observed, a statement regarding injection accuracy, a list of areas 
receiving injections, an image analysis of injection sites or sites judged to bear increased 
staining as a result of the treatment and, a statement regarding hemispheric variation. 
Injection accuracy refers to the degree of certainty with which it can be declared that an 
injection entered the hippocampus. Injection tracks are used to determine if accuracy can 
be credited to a given injection. The localization of an injection track tended to get more 
difficult as the survival time increased. For this reason, results will be discussed with 
respect to injection accuracy such that all results will first be considered together and then 
again with questionable injection data removed. In the case of animals demonstrating a 
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difference in staining between control and experimental hemispheres, a dimensional 
analysis (length, width and depth measures) will be provided along with a statement 
assessing the location of injections relative to sites of stain increases. 
ONE DAY SURVIVAL GROUP: 
GENERAL RESULTS: 
Of the nine subjects included in the one day survival group, none demonstrated 
any AChE staining increase in QNB injected hippocampi. Acetylcholinesterase staining 
patterns in controls did not differ from patterns observed in experimental hemispheres. 
INJECTION ACCURACY: 
QNB INJECTIONS: Out of the nine subjects in total , eight were judged to have 
confirmed QNB injections into the hippocampus. The injection track of one subject was 
unable to be located due to tissue damage in the QNB injected hippocampus. 
VEHICLE INJECTIONS: Out of the full complement of vehicle injections, seven 
were judged to have accurate placements such that tracks could be located entering the 
respective hippocampi. Two of the nine subjects were judged to have questionable 
vehicle injections. Figure 2 illustrates QNB and vehicle injection sites in a one day 
subject. 
Figure 2. Photomicrograph of QNB treated (top) and 
corresponding vehicle treated (bottom) hippocampi 
from a one day survival subject. 
Open arrows indicate injection site. 
Abbreviations: RH = right hemisphere 
LH = left hemisphere 
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AREAS OF INJECTION: 
QNB INJECTIONS: Of the eight QNB injections judged to have entered the 
hippocampus, five were found in the DG and one each in CAl, SLM and CA3. 
VEHICLE INJECTIONS: Of the seven hippocampal vehicle injections identified, 
four were found in CA3 and one in each of CA 1, DG and SLM. 
DENSITY ANALYSIS: 
QNB INJECTED REGIONS: A density analysis of QNB injected areas within the 
hippocampus was performed. Sampled QNB injected sites were found to have a mean 
normalized ROD value of 1.71 (SD = .30) with a range of 1.26 to 2.09. These 
calculations include image analysis measurements from all animals irrespective of QNB 
injection accuracy. The mean normalized ROD value of corresponding control sample 
areas was 1.74 (SD = .29) with a range of 1.27 to 2.08. Figure 3 illustrates the mean 
ROD scores of all one day survival group subjects irrespective of QNB injection 
accuracy. The mean QNB treated area ROD as a percent of the corresponding control 
ROD values was 98 percent. 
With the scores of the subject demonstrating a questionable injection removed, the 
mean normalized ROD of the QNB injected targets was 1. 77 (SD = .26) with a range 
of 1.37 to 2.08. The mean normalized ROD value of corresponding control samples was 
1. 79 (SD = .29) with a range of 1.26 to 2.08. Figure 4 illustrates the mean ROD scores 
of one day subjects with questionable QNB injections removed from the analysis. The 
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FIGURE 4 . MEAN ROD SCORES OF 1 DAY SURVIVAL 
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mean QNB trea ed area ROD as a percent of the corresponding control ROD is 101 
percent. 
VEHICLE INJECTED AREAS: The mean normalized ROD value of vehicle 
injection sites was 1.63 (SD = .37) with a range ROD of 1.21 to 2.35. The mean 
normalized ROD value of corresponding control samples in the QNB hemisphere was 
1.56 (SD = .29) with a range of 1.25 to 2.01. The mean normalized vehicle injection 
ROD was found to be 104 percent of the mean normalized ROD value of the 
corresponding co ntrol samples of the other hemisphere. These calculations include the 
ROD values of su bjects with questionable vehicle injections. Figure 3 illustrates the mean 
ROD scores of subjects irrespective of vehicle injection accuracy. With the questionable 
scores removed from the analysis, the mean normalized ROD of vehicle injection sites 
was 1.66 (SD = .42) compared with 1.58 (SD = .33) for corresponding control 
hemisphere sampJes with a range ROD of 1.2 to 2.0. Figure 4 illustrates the mean ROD 
values of subjects in the one day survival group with questionable vehicle injections 
removed from the analysis. In this case, the mean normalized vehicle injection ROD was 
105 percent of the normalized ROD of its corresponding QNB control samples. 
HEMISPHERE V ARIATION: 
Of the ni11e subjects used in the one day survival group, four received left 
hemisphere QNB injections and five received right hemisphere QNB injections. Neither 
hemispherically d j fferentiated group showed any enhancement of AChE staining at the 
4 1 
point of drug injection. No other noticeable difference between these subjects W <LS 
observed. 
CHARACTERISTIC INJECTION TRACK STAINING OF THIS GROUP: 
Subjects of the one day survival group with clear injection tracks display increased 
staining within the track itself while not in surrounding tissue. See figure 2 for an 
illustration of this in left and right hippocampi of a subject. 
FOUR DAY SURVIVAL GROUP: 
GENERAL RESULTS: 
Seventeen subjects formed the four day group in this experiment. Of the 17, 12 
subjects (70.6 percent) demonstrated an AChE positive stain increase that correlated wi th 
the site of QNB injection in either the right or left hemispheres. Five animals did not 
demonstrate an AChE positive stain increase in either QNB or vehicle hemispheres. 
INJECTION ACCURACY: 
QNB INJECTIONS: Of the full complement of subjects, 15 had QNB injections 
judged to be in the hippocampus. Two subjects were judged to have had questionable 
QNB injections in that the injection tracks were not readily traceable or seen entering the 
hippocampus. 
VEHICLE INJECTIONS: Eleven of the 17 subjects were judged to have obvious 
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and accurate hippocampal vehicle injections while six did not. 
STAIN EFFECT AND ACCURACY OF INJECTION: Of the 15 subjects with 
confirmed QNB hippocampal injections, 11 were observed to demonstrate some degree 
of AChE positive stain increase at the site of injection. Four of fifteen did not. Of the 
two subjects with questionable QNB injections, one displayed an AChE positive stain 
increase while the other did not. 
AREAS OF STAIN INCREASES: 
Twelve subjects of the four day survival group were judged to possess an AChE 
positive stain increase in the QNB injected hemisphere relative to corresponding controls. 
From this number, 15 distinct areas of stain increase were observed such that each subject 
showed an increase in at least one region while three subjects had an increase in tw\) 
areas. 
The largest number of AChE positive stain increases were seen in the DG. Eleven 
subjects demonstrated an increase in this region whether in the lateral or medial blade . 
In some cases AChE positive stain increases could be seen in the granule cell layer which 
is normally devoid of AChE staining. Four of the AChE stain increases were seen in 
CA 1 of the hippocampus through strata oriens, pyramidale and superficial radiatum. See 
figure 5 for an illustration of QNB and vehicle injected hippocampal tissue of 
representative four day subjects. 
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Figure 5. Photomicrographs of four day survival subjects 
with AChE positive stain increases in the molecular layer 
of the DG (top left and lower left) . 
Adjacent pictures are corresponding vehicle treated 
hippocampi. 
The middle photomicrographs are vehicle injected (right) 
and corresponding QNB treated (left) hippocampi of the 
subject displaying an AChE stain increase in the top left 
photomicrograph. AChE staining in the vehicle injected 
hippocampus (middle right), its corresponding QNB 
side control (middle left) and the QNB injection control 
(top right) does not differ. 
Abbreviations: RH right hemisphere 
LH = left hemisphere 
RH LH 
LH 
RH lH 
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AREAS OF INJECTION WITH NO OBSERVED STAIN INCREASE: 
Five animals of the four day survival subjects did not exhibit an AChE positive 
stain increase. Of these, one had a QNB injection into region CA3. Another subject had 
an injection into the lateral blade DG while two others had injections yet no reaction in 
SLM. 
DIMENSIONAL ANALYSIS: 
WIDTH MEASURE: The width (medial to lateral plane) of observed AChE positive 
stain increases in QNB injected hemispheres was obtained for each subject demonstrating 
a stain difference at the point of greatest increase. Twelve subjects were found to exh1bit 
an AChE positive stain increase in QNB injected hippocampi and 15 distinct sites of 
increase were observed in these 12. The mean width of the AChE positive stain increa~ 
at QNB injected sites was . 79 mm (SD = .96) with a range of .11 mm to 4.0 mm. This 
mean was calculated using the results of a subject which demonstrated a diffuse increa 'e 
in staining throughout the DG of 4.0 mm in width. With this extreme score removed 
from the analysis, the mean length is .56 mm (SD = .39) and the range is .11 mm to 
1.39 mm. 
DEPTH MEASURE: The mean depth (dorsal to ventral plane) of AChE positive stain 
increases was .223 mm (SD = .2397) including all animals. The range of depth 
measures was from .06 mm to .39 mm. Excluding the depth measure from the subject 
demonstrating a diffuse pattern of staining through the DG, the mean depth was .23 mm 
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(SD - .24) ranging from .06 mm to .39 mm. 
DENSITY ANALYSIS: 
QNB INJECTED STAIN INCREASES: The mean normalized ROD value for 
regions of observed AChE increase in QNB injected hemispheres was 2.36 (SD = .41) 
with a range of 1.88 to 3.06. The mean normalized ROD of the corresponding area in 
the other hemisphere was 1.87 (SD = .41) with a range of 1.24 to 2.50. Figure 6 
illustrates the mean ROD scores of subjects illustrating an AChE stain increase at the 
QNB injection site. Quinuclidinyl benzilate injected samples demonstrating a stain 
increase had average ROD values 136 percent of those of corresponding controls areas. 
Of the QNB injected subjects not displaying a stain increase, the mean normalized 
ROD value was 1.70 (SD = .42) with a range of 1.30 to 2.07. Subjects with stam 
' 
increases have ROD values 149 percent of those noneffective QNB injected subjects. 
Those subjects receiving QNB injections yet not displaying a stain increase had 
normalized ROD values that were 98 percent of the corresponding control samples. 
The above analysis of AChE stain increases includes the results of one subject 
that, although exhibiting an increase in staining, has a questionable QNB injection. With 
the questionable injection removed, the mean normalized ROD value for QNB samples 
became 2.55 (SD = .41) with a range of 1.88 to 3.06. The mean ROD value of 
corresponding control samples was 1.91 (SD = .39) with a range of 1.24 to 2.50. 
Figure 7 illustrates the mean ROD scores of four day survival group subjects with 
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questionable injections removed. On average, QNB injected sample ROD values were 
134 percent of corresponding vehicle control values. 
VEHICLE INJECTED REGIONS: The mean normalized ROD value for sampled 
regions of vehicle injected hemispheres was 1.65 (SD = .32) with a range of 1.23 to 
2. 27. Corresponding control sites in the opposite hemisphere had a mean normalized 
ROD of 1.70 (SD = .20) with a range of 1.36 to 2.16. Figure 6 illustrates the mean 
vehicle injection and control ROD scores of four day subjects. The mean normalized 
ROD of vehicle injected samples was 97 percent of QNB injected control counterparts. 
These calculations were based on the entire pool of vehicle injected hemispheres 
irrespective of apparent vehicle injection accuracy. With those ROD values of 
questionable vehicle injections and their corresponding QNB controls removed, the mean 
normalized ROD of vehicle injected samples was 1. 71 (SO = .34) while the same 
. 
measure of corresponding QNB control samples was 1.72 (SO = .20). The range of 
ROD values for vehicle injected samples was 1.40 to 2.27 while the range for 
corresponding control ROD values was 1.52 to 2.16. Figure 7 illustrates the mean ROD 
values of four day subjects with questionable vehicle injection samples removed from the 
analysis. Vehicle injection sample ROD values were, on average, 97 percent of control 
QNB values. 
LENGTH OF AChE INCREASES: 
Of the 12 subjects demonstrating an increase in AChE positive staining, 15 areas 
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of increase within the hippocampus were noted. The mean length (anterior to posterior 
plane) of this increase through the hippocampus was found to be 658.7 llm (SD = 420.0 
llm) with a range of 160 llm to 1680 ~m. 
LENGTH AND AREA OF INCREASE: 
Of the 15 areas of AChE stain increase observed, 11 were found to be in the DG. 
The mean length of increase through this region was 687.3 llm (SD = 464.0 llm) wlth 
a range of 160 llm to 1680 llm. Four sites of stain increase were found in area CAl. 
The mean persistency of the increase was 580 ~m (SD = 307.3 llm) with a range of240 
llffi to 840 llffi. 
HEMISPHERE VARIATION: 
Of the 12 subjects demonstrating an increase in AChE positive staining, nine 
received QNB injections in the right hippocampus while three received injections into the 
left hemisphere hippocampus. This included one right hemisphere injected subject with 
a questionable injection. 
Three subjects receiving an injection of QNB into the left hemisphere yet not 
demonstrating an AChE stain increase did not have questionable QNB injections. Of t'AO 
receiving right hemisphere QNB injections and not demonstrating an AChE positive stain 
increase, one had a questionable QNB injection. 
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FOURTEEN DAY SURVIVAL GROUP: 
GENERAL RESULTS: 
Nine animals were included in the 14 day survival group. Three (33.3 percent) 
demonstrated some degree of AChE positive stain increase in QNB injected hemispheres 
relative to corresponding vehicle controls. The regions of AChE stain increase correlated 
with the QNB injection sites. Six subjects did not demonstrate an AChE positive increase 
at the QNB injection site. 
INJECTION ACCURACY: 
QNB INJECTIONS: Of the three subjects demonstrating an increase in AChE 
positive staining, all were judged to possess accurate QNB injection sites. 
Of the six subjects with no observed stain increase, two had questionable QN~ 
injections, while four had QNB injections judged to be accurate. 
VEHICLE INJECTIONS: Out of the three subjects exhibiting an increase in 
AChE positive staining two had vehicle injections that were judged to be questionable . 
Of the six subjects with no observed increase in AChE staining, two were judged to 
possess questionable vehicle control injections. 
AREAS OF STAIN INCREASE: 
A total of three subjects were observed to have increased AChE staining. Two 
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subjects demonstrated an increase in one area while another subject had an increase in 
two regions. Two areas of stain increase were located in the DG and one each in CA 1 
(through strata oriens, pyramidal and superficial radiatum) and the cortex respectively. 
Of the AChE positive stain increases in the DG, one was seen to penetrate the granule 
cell layer of the lateral blade, an area normally devoid of AChE staining. Figure 8 
illustrates 14 day survival subjects demonstrating an AChE positive stain increase. 
AREAS OF ONB INJECTION WITH NO OBSERVED INCREASE: 
Of the subjects judged to possess accurate QNB injections yet no stain increase , 
five received an injection into CAl while one received an injection in SLM lateral to DG. 
DIMENSIONAL ANALYSIS: 
WIDTH: The mean width (medial to lateral plane) of regions possessing an AChE 
positive stain increase was .63 mm (SD = .14) with a range of .50 mm to .78 mm. 
DEPTH: The mean depth (dorsal to ventral plane) of increased AChE positive 
stained regions was .35 mm (SD = .31) with a range of .15 mm to . 72 mm. 
DENSITY ANALYSIS: 
QNB INJECTED REGION SAMPLES: Normalized ROD values ofQNB injected 
hemispheres were taken from regions of greatest stain increase and in the case of no stain 
increase, from injection sites. The mean normalized ROD value for all nine QNB 
5 3 
Figure 8. Photomicrographs of 14 day subjects with AChE 
positive stain increases in the medial and lateral blades 
of the DG (top and middle photomicrographs on the left 
respectively) and the cortex (bottom left). Adjacent 
photomicrographs on the right are corresponding vehicle 
injected hippocampi. 
Black arrows indicate AChE positive stain increases and 
open arrows indicate injection sites or tracks. 
The photomicrograph situated in the middle and left 
demonstrates a clear AChE positive stain increase in the 
molecular and granule cell layers. The latter is usually 
devoid of AChE positive fibers. 
Abbreviations: RH = right hemisphere 
LH = left hemisphere 
RH Ll-i 
RH LH 
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injected hemisphere samples was 1.92 (SO = .37) with arange of 1.49 to 2.64. The 
same measure of corresponding vehicle control samples was 1. 78 (SD = .54) with a 
range of 1.24 to 2.89. Figure 9 illustrates the mean ROD scores of all subjects 
irrespective of injection accuracy. The average normalized ROD of QNB injected regions 
sampled was 119 percent of the corresponding vehicle control samples. 
Including only the three subjects demonstrating an AChE staining increase on 
QNB injected hippocampi, the mean normalized ROD value became, 2.13 (SD = .48) 
with a range of 1.68 to 2.64. The same measures of the corresponding vehicle control 
region samples produced a mean ROD of 1.38 (SD = .24) with a range of 1.24 to 1.66. 
The average ROD value of QNB injected samples observed to possess an increase was 
154 percent of corresponding vehicle control samples. 
Removing all samples taken from those subjects possessing questionable QNB 
injections the mean normalized ROD of QNB injected hippocampi was 1.97 (SD = .39) 
with a range of 1.49 to 2.64. The mean score of corresponding vehicle controls was 1.64' 
(SD = .39) with a range of 1.24 to 2.34. Figure 10 illustrates the mean ROD scores of 
14 day survival subjects with questionable QNB injection results excluded. The average 
QNB ROD value became, in this case, 118 percent of control values. 
VEHICLE INJECTED REGION SAMPLES: The mean normalized ROD value 
of vehicle injected hemisphere samples was 1.94 (SD = .74) with a range of 1.25 to 
3.73. The same calculation for corresponding QNB control samples was 1.95 (SD = 
.51) with a range of 1.59 to 3.21. Figure 9 illustrates the mean ROD values of all 14 
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FIGURE 10. MEAN ROD SCORES OF 14 DAY SUBJECTS WITH 
ACCURATE INJECTIONS ONLY 
0 
0 
~ 
0 
~ 
N 
.......... 
~ 
< 
3.0 
2.5 
~ 2.0 
0 
z 
z 
< 
~ 
::s 1.5 
~ QNB INJECTION 
SAMPLE ROD 
00 VEHICLE CONTROL 
~ VEHICLE INJECTION 
SAMPLE ROD 
.bhiJ QNB CONTROL 
58 
day subjects. The average vehicle injection normalized ROD value was 99.4 percent of 
corresponding control values. 
Removing the scores of all samples taken from subjects with questionable vehicle 
injections, the mean normalized ROD of vehicle injected hippocampi was 1. 72 (SD = 
.40) with a range of 1.25 to 2.34. The same measure for corresponding QNB controls 
was 1.84 (SD = .21) with a range of 1.6 to 2.19. Figure 10 illustrates the mean ROD 
scores of subjects with questionable vehicle injection scores removed from the analysis. 
The normalized ROD values of vehicle injection sites sampled were on average, 93 
percent of corresponding control values. 
LENGTH OF STAIN INCREASE: 
The mean length (anterior to posterior plane) of stain increases through the QNB 
injected hemisphere was 426.7 ~m (SD = 220.30 ~m) with a range of 280 ~m to 680 
~m. 
HEMISPHERE V ARIATJON: 
Of the three subjects demonstrating an increase in AChE positive staining, one 
received an injection of QNB into the left hemisphere. The other two received right 
hemisphere QNB injections. 
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TWENTY-ONE DAY SURVIVAL GROUP: 
GENERAL RESULTS: Eight subjects were included in the 21 day survival group. Of 
these, none demonstrated an increase in AChE positive staining on QNB or vehicle 
injected hemispheres. 
INJECTION ACCURACY: 
QNB INJECTIONS: Six out of eight subjects had QNB injection tracks judged 
to be in the hippocampus. Two of eight QNB injections were judged to be questionable. 
VEHICLE INJECTION: Of the eight subjects, three were judged as possessing 
questionable vehicle injections. The remaining five were judged to have accurate vehicle 
injections that entered the hippocampus. 
AREAS OF INJECTION: 
Of six subjects with confirmed QNB injection tracks, one was in SLM, two were 
in the DG and three were in area CA 1. 
Of the five accurate vehicle injections, one was found in CA3, two in CA 1, one 
in CA4 and one in DG. Figure 11 illustrates QNB injection and vehicle injection sites of 
a 21 day survival subject. 
6 0 
Figure 11. Photomicrographs of QNB injected (left) and 
corresponding vehicle injected (right) hippocampi of 21 
day survival subjects. 
Open arrows indicate injection sites where found. 
Abbreviations: RH 
LH 
= right hemisphere 
left hemisphere 
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DENSITY ANALYSIS: 
QNB INJECTION SAMPLES: The mean normalized ROD value of QNB injected 
regions of the 21 day survival group was 1.71 (SD = .25) with a range of 1.36 to 2.10. 
The mean normalized ROD value of corresponding vehicle control samples was 1.67 (SD 
= .32) with a range of 1.28 to 2.20. Figure 12 illustrates the mean ROD scores of all 
21 day subjects. QNB injected regions sampled were on average, 102 percent of 
corresponding control normalized ROD values. 
The above calculations were the result of pooling the image analysis data of all 
21 day subjects regardless of QNB injection accuracy. With those samples derived from 
questionable injections removed from the analysis, the mean normalized ROD of QNB 
injected samples was 1.63 (SD = .21) with a range of 1.36 to 1.94. The corresponding 
vehicle control value on the same measure was 1.60 (SD = .29) with a range of 1.28 to. 
2.14. Figure 13 illustrates the mean ROD values of QNB injected samples with 
questionable injection scores removed. QNB injection ROD values were on average, 102 
percent of corresponding control values. 
VEHICLE INJECTION SAMPLES: The mean normalized ROD value of vehicle 
injected regions of the 21 day group was 1.60 (SD = .26) with a range of 1.34 to 2.20 . 
The same calculation for corresponding QNB control samples was 1.63 (SD = .21) with 
a range of 1.37 to 2.10. Figure 12 illustrates the mean ROD scores of all 21 day survival 
subjects. On average, the mean ROD values of vehicle injection samples were 98 percent 
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FIGURE 13 . MEAN ROD SCORES OF 21 DAY SURVIVAL 
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of corresponding control values. 
When the ROD values of subjects with questionable vehicle injections were 
removed from the analysis, the mean ROD value for vehicle samples was 1.51 (SD = 
.04) with a range of 1.46 to 1.57. Corresponding QNB control samples had a mean 
normalized ROD value of 1.56 (SD = .05) with a range of 1.52 to 1.65. Figure 13 
illustrates the mean ROD scores of subjects with the results of questionable vehicle 
injections removed. Vehicle regions sampled have an average normalized ROD value that 
was 96 percent of corresponding QNB control ROD values. 
HEMISPHERE VARIATION: 
Two of eight subjects in the 21 day survival group received QNB injections into 
the left hippocampus while the other six received injections into the right hippocampus. 
Neither the left or right QNB injected hemispheres demonstrated an AChE positive stain 
mcrease. 
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EXPERIMENT TWO 
INTRODUCTION 
Thus far, the present study has demonstrated that prolonged muscarinic receptor 
blockade can induce AChE positive staining increases in the hippocampus of female adult 
rats of four and 14 day survival groups but not in one and 21 day survival groups. While 
this is true, the results suggest a degree of variability such that there were a number of 
subjects with clear QNB injections that did not demonstrate an AChE positive stain 
increase. There were also a large range of results on the dimensional analysis measures 
undertaken to define the extent of staining increases when they occurred. It was decided 
that this could possibly have been due to the QNB concentration used. Perhaps, the effect 
is dependent on enough muscarinic receptors being antagonized in a given area. While 
a 20 ~g QNB concentration in 2 ~1 of vehicle was obviously adequate for the most part 
(70.5 percent of four day subjects in experiment one), it may be that coupled with other 
• 
variables such as the location of targets, this QNB concentration was not as effective as 
a higher one may be. This possibility was investigated in experiment two. 
The results of experiment one can only be generalized to a population of female 
rats of the Sprague Dawley strain. The possibility of sex related effects regarding 
responses to prolonged muscarinic blockade is not expected but at the same time, not 
immediately dismissable. 
A concern when using female subjects is the occurrence of estrous effects on the 
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measure(s) under study. With the exception of the one day survival group, the 
manipulations of experiment one lasted at least a complete estrous cycle. Because of this 
it is likely that the estrous cycle was not a concern. The probability exists that periods 
of estrous were spread out randomly across each experiment such that the impact of its 
occurrence did not effect one group more than another. In experiment one, no effort was 
made to determine the stage of the estrous cycle rats under study were in. As well as 
assessing the effect of a higher concentration of QNB, experiment two attempted to 
address the concern of possible sex related differences regarding the increased AChE 
positive staining response to prolonged muscarinic antagonism. Further, the hemisphere 
of QNB treatment was also monitored as a possible source of staining differences in 
response to QNB injection. 
It was predicted in experiment two that the 20 '-'g/2 '-'1 dosage will induce ACh~ 
positive staining increases within treated hippocampi. It was also predicted that a higher 
dose (40 Jlg/2 Jil) would, as well, induce an increase in staining and that this increaSe 
would be denser than increases produced by the lower dose. With respect to the sex of 
treated animals or the hemisphere of treatment, no differences were expected. 
EXPERIMENT TWO 
METHOD. 
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Subjects: The subjects used in experiment two were four male and four 
female Sprague Dawley rats. See experiment one methods section for details of weight, 
storage and maintenance. 
Procedure: The subjects of this experiment were treated as per the procedure of 
experiment one with the following considerations. Half of each group of males and 
females received the usual 20 ~g concentration of QNB in a 2 ~1 volume while the others 
received 40 ~g of the drug in an equal volume. In half of the cases, QNB was injected 
into the right hemisphere while in the other half, QNB was injected into the left 
hemisphere. In all cases, the vehicle was injected into the hemisphere opposite to that 
in which QNB was injected. 
STATISTICS: A statistical analysis was conducted on the data of experiment two. 
\ 
There were insufficient data points per treatment (sex, QNB concentration, hemisphere) 
to merit a comprehensive analysis of variables together; therefore, the variables were 
assessed individually. Student paired t-tests were computed for sex, QNB dose and 
hemisphere data with respect to density measure scores. Analysis of QNB injection ROD 
samples compared to vehicle injection ROD samples were reported in the "summary 
results" section along with other analyses that attempted to identify and characterize 
statistically the effect of the treatment both between and within the groups. 
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EXPERIMENT TWO RESULTS: 
GENERAL RESULTS: 
Eight animals sacrificed four days following QNB/vehicle treatment were used in 
this experiment. Of the eight, five (62.5 percent) demonstrated an AChE positive stain 
increase in QNB injected hippocampi relative to corresponding vehicle controls. Figure 
14 illustrates representative AChE positive stain increases seen in experiment two. 
INJECTION ACCURACY: 
QNB INJECTIONS: Of the five subjects demonstrating an AChE positive stain 
increase, four were judged to have accurate QNB injections while one was not. Three 
subjects of the group were not found to demonstrate an AChE positive stain increase. 
One of these had a QNB injection judged to be reliable while the other two did not. . 
. 
VEHICLE INJECTION. Of eight subjects included in the analysis, two were 
judged to have questionable vehicle injections. Of these, one was observed to 
demonstrate a stain increase in the QNB injected hippocampus. 
GENDER. DOSE. HEMISPHERE DIFFERENCES: 
FEMALE/DOSE/HEMISPHERE: Of the four females used in this experiment, 
two demonstrated an increase in AChE positive staining. One of the two subjects 
exhibiting a positive stain increase received a 20 ~g dose of QNB while the other 
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Figure 14. Photomicrographs of QNB (20 ~g/2 ~1) injected 
(top) and corresponding vehicle injected hippocampi of an 
experiment two 4 day male subject (Note: tear 
occurred during the mounting process) . 
Black arrow indicates AChE positive stain increases and 
the open arrows indicate injection sites or tracks. 
The DG in the QNB injected hippocampus (top) demonstrated 
darker AChE positive staining than the corresponding 
vehicle treated hippocampus. The white bands seen in the 
vehicle side molecular layer are absent in the treated. 
hippocampus. 
Abbreviations: RH = right hemisphere 
LH = left hemisphere 
'11 
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received a 40 ~g dose. Of the two instances of increase, one QNB injection was located 
in the right hippocampus while the other was in the left. 
MALE/DOSE/HEMISPHERE: Of the four males used, three (75 percent) were 
found to demonstrate an AChE positive stain increase in the QNB injected hippocampus 
relative to corresponding controls. Of the three positive responses, two received 40 ~g 
doses of QNB while the third received a 20 ~g dose. Two of the increases were 
observed in the right hippocampus while one was observed in the left. Table 2 illustrates 
the results of experiment two by subject, sex, dose, hemisphere of injection, staining 
effect and injection accuracy. 
AREAS OF ST AIN1NG INCREASE: 
Of five subjects observed to demonstrate an increase in AChE positive staining in 
QNB injected hippocampi, six distinct areas demonstrating this increase were observed. 
Of these, two were in the DG (molecular layer and granule cell layer) and four were in 
area CAl (through strata oriens, pyramidale and superficial radiatum). 
Of the subjects not seen to exhibit an AChE stain increase, one had a defin ite 
QNB injection into the DG while two others had questionable QNB injections. 
DIMENSIONAL ANALYSIS: 
WIDTH: The mean width (medial to lateral plane) of AChE positive stain 
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Table 2. Experiment two results table. 
QNB AchE 
SUBJECT DOSE SEX INJECTION HEMISPHERE STAIN 
1 40jJg F IN R YES 
2 40JJg F IN L NO 
-
3 40JJg M IN R YES 
4 40jjg M ? L YES 
5 20JJg F IN L YES 
6 20JJg F ? R NO 
7 20p.g M IN R YES 
8 20p.g M ? L NO 
For each subject used in the experiment, the QNB dose (20p.g/40p.q) 1 
the subject's sex (M/F), the accuracy of QNB injection (IN/?), the 
hemisphere of injection (R/L) and the occurence of an AchE positive 
stain increase (YES/NO) are illustrated. 
ABBREVIATIONS: F=female, M=male, IN= accurate QNB injection, 
?=questionable QNB injection, R=right, L=left, YES=stain increase 
seen, NO=no stain increase seen. 
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increases in QNB injected hippocampi of experiment two was .54 mm (SD .46 mm) with 
a range of .14 mm to 1.44 mm. 
DEPTH: The mean depth (dorsal to ventral plane) of AChE positive stain 
increases in QNB injected hippocampi was .14 mm (SD .0683) with a range of .06 mm 
to .22 mm. 
IMAGE ANALYSIS: 
QNB INJECTED HIPPOCAMPI SAMPLES: The mean normalized ROD value 
of QNB injected samples was 2.01 (SD = .44) with a range of 1.17 to 2.62. The same 
calculation for corresponding vehicle control samples yielded a mean of 1.54 (SD = .28) 
with a range of 1.26 to 2.02. Figure 15 illustrates the mean ROD scores of all 
experiment two subjects irrespective of QNB injection accuracy. The average QN~ 
injected ROD value was 131 percent of vehicle control sample values. 
. 
The above analysis includes all QNB injected subject samples regardless of 
injection accuracy. With the scores of subjects possessing questionable QNB injections 
removed, the mean ROD value became 2.05 (SD = .24) with a range of 1. 72 to 2.34 . 
The mean of corresponding vehicle control samples became 1.50 (SD = .226) with a 
range of 1.27 to 1.84. Figure 16 illustrates the mean ROD scores of experiment two 
subjects with questionable QNB injections removed from the analysis. The average QNB 
injected ROD value is 136 percent of vehicle control sample ROD values. 
If only subjects demonstrating An AChE positive stain increase were included in 
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the analysis, the mean normalized ROD was 2.13 (SD = .34) with a range of 1. 72 to 
2.62. The same measure of corresponding vehicle controls was 1.58 (SD = .30) with 
a range of 1.27 to 1.84. The QNB injected samples are on average 135 percent of 
corresponding vehicle control values. 
VEHICLE INJECTION SAMPLES: The mean normalized vehicle injection 
sample ROD was 1.54 (SD = .21) with a range of 1.31 to 1.96. The same calculations 
of the QNB control samples yielded a mean of 1.58 (SD = .13) with a range of 1.37 to 
1.83. Figure 15 illustrates the mean ROD scores of experiment two subjects irrespective 
of vehicle injection reliability. On average, vehicle injection samples possessed a 
normalized ROD value which was 98 percent of corresponding controls. 
The above calculations were based on the image analysis results of all animals 
pooled. If the questionable vehicle injection scores were removed from the analysis, the 
mean ROD of vehicle injection samples became 1.63 (SD = .19) with a range of 1.4'3 
to 1.96. The mean normalized ROD value of corresponding QNB control samples 
became 1.60 (SD = .16) with a range of 1.37 to 1.83. Figure 16 illustrates the mean 
ROD scores of subjects with questionable vehicle injection sample scores removed. On 
average, vehicle injected samples had a normalized ROD value that was 102 percent f 
corresponding QNB control sample ROD values. 
LENGTH OF OBSERVED AChE POSITIVE STAIN INCREASES: 
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Of the five animals demonstrating the AChE positive stain increase, the mean 
length (anterior to posterior plane) through the hippocampus was 526.7 llm (SD = 530.3 
llm) with a range of 80 llm to 1520 J.lm. 
AREA OF INCREASE AND LENGTH: 
DG: Of the three sites of observed AChE increase in the DG, the mean length 
was 760 llm (SD = 723.3 llm) with a range of 80 llm to 1520 J.lm. 
CA 1: Three regions of stain increase observed in CA 1 had a mean length of 
293.3 J.lin (SD = 128.6) with a range of 200 llm to 440 J.lm. 
STATISTICS: 
Sex: A Student paired t-test was conducted to determine if a difference existed on the 
' 
QNB injection ROD measure with respect to sex of the subjects. No differences were 
found between male and female subjects in experiment two with respect to QNB injection 
ROD measures (t = -1.66). 
HEMISPHERE: A Student paired t-test was computed to determine if differences 
existed between hemispheres with respect to QNB injection sample ROD values. No 
significant differences were found on the QNB injection ROD measure between 
hemispheres of QNB treatment (t = -1.88). 
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SUMMARY ANALYSIS 
AChE POSITIVE INCREASES: Figure 17 illustrates the percent of subjects in the 
respective groups that demonstrated an increase in AChE positive staining in the QNB 
injected hemisphere. Two survival time periods were found to show a stain increase 
while two did not. Both four (experiment one and two) and 14 day groups demonstrated 
a degree of staining increase in QNB injected hippocampi while 21 and one day groups 
did not. In the 14 day group, 33.3 percent of subjects displayed a stain difference 
favoring the QNB injected hippocampus. Of all subjects in the four day (experiment one) 
group, 70.6 percent of subjects demonstrated an AChE positive stain increase. A total 
of 62.5 percent of subjects demonstrated a stain increase in the four day group of 
experiment two. If the results of all subjects of the four day sacrifice condition are 
pooled from experiments one and two, then 68 percent of all four day subjects 
demonstrated some degree of AChE stain increase in QNB injected hippocampi. 
INJECTIONS VERSUS CORRESPONDING CONTROLS: 
QNB INJECTION: Figure 18 illustrates the QNB injection sample ROD values as a 
percent of corresponding vehicle control ROD values. In this analysis only subjects with 
accurate injection sites were included. One day QNB injection samples on average had 
ROD values 101 percent of control scores. Four day (experiment one) QNB injection 
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FIGURE 18 . QNB INJECTION SAMPLE ROD VALUES AS A PERCENT 
OF CORRESPONDING VEHICLE CONTROL VALUES. 
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samples were found to be 134 percent of control values while four day (experiment two) 
QNB injection values were 136 percent of control values. Fourteen day QNB injection 
samples were found to be, on average, 118 percent of control sample ROD values while 
21 day QNB injected samples were found to be 102 percent of control levels. 
VEHICLE INJECTION: Figure 19 illustrates the vehicle injection ROD values as a 
percentage of their corresponding QNB control values. Again, only subjects with 
injections judged to be accurate were included. One day vehicle injection samples were 
found to be 105 percent of corresponding control values. Four day (experiment one) 
vehicle injection ROD samples were 97 percent of corresponding QNB control samples. 
Four day (experiment two) vehicle injected samples were found to be 102 percent of QNB 
control ROD scores. Fourteen and 21 day vehicle injection samples taken were 
determined to be 93 and 96 percent of QNB control values respectively. 
STATISTICAL ANALYSES: 
CONTROL FOR QNB INJECTION: For each subject in this study, the density 
analysis results consisted of four measures as outlined in experiment one methods section. 
This includes one QNB injection sample ROD, a vehicle injection sample ROD and t~o 
injection control sample ROD values (QNB control and vehicle control). The existence 
of this number of controls (3) makes data analysis cumbersome. It was decided therefore 
to compare QNB injection samples with vehicle injection samples only. To 
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FIGURE 19 .VEHICLE INJECTION SAMPLE ROD VALUES AS A PERCENT 
OF CORRESPONDING QNB CONTROL SAMPLES 
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justify this, comparisons were calculated between a pooled (across all groups) vehicle 
injection sample mean and the pooled injection control sample mean using the Student t-
test for dependent samples. The pooled vehicle injection ROD samples did not 
significantly differ from the means of the two injection control ROD values. The pooled 
vehicle injection ROD (mean = 1.67 , SD = .33) was not found to be significantly 
different from its control (mean = 1.76, SD = .42l)(t = -1.20). The pooled vehicle 
injection ROD (mean = 1.67 , SD = .333) was also not found to differ significantly 
from the QNB injection control ROD (mean = 1.67 , SD = .243 ; t = -.39). Because 
the vehicle injection samples did not differ significantly from the injection controls, all 
comparisons requiring a control value used the vehicle injection sample ROD. 
BETWEEN GROUP ANALYSIS: 
A statistical analysis of the density results of all subject scores from experimental 
and control conditions between groups (survival times) was conducted. This analysis 
included the normalized ROD data of all subjects of each group that demonstrated 
accurate QNB or vehicle injections. If the effects of QNB and the vehicle were to be 
evaluated in this study, then those subjects demonstrating that the injections of each were 
accurate best served the analysis. If those subjects with questionable injections were 
included, then a measure of the treatment effect would not truly have been assessed since 
these subjects may not have received the treatment. 
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ONB INJECTION ROD SAMPLES BY GROUP: 
A one way ANOV A was conducted to analyze the QNB injection sample ROD 
results by group. This analysis produced significant results (f(4,36) = 4.10 , p = .007) 
indicating that there was a significant difference between groups with respect to the QNB 
injection ROD measure. To identify the source of this difference, post hoc comparisons 
were conducted using the Tukey test. Significant differences (p < .05) were found, with 
respect to the QNB injection ROD scores, between the four day survival group of 
experiment one and the one and 21 day survival groups. The four day survival group of 
experiment one was not found to be significantly different from the four day group of 
experiment two or the 14 day group. 
VEHICLE INJECTION ROD SAMPLES BY GROUP: 
A one way ANOV A was conducted to analyze the vehicle injection sample ROD 
scores by group. As expected, the groups did not differ with respect to vehicle injectio~ 
ROD scores (f(4,27) = .397). 
HEMISPHERE DIFFERENCES: 
QNB INJECTION ROD VALUES BY HEMISPHERE: 
A MANOV A was conducted to analyze ROD measures of QNB injected samples 
with respect to the independent variables of treatment hemisphere and group. No 
statistical difference was found to exist between QNB injection ROD values obtained from 
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right and left hemispheres for each group. That is, there were no group differences on 
the QNB injection ROD measure with respect to hemisphere. (F(3,32) = .79) 
VEHICLE INJECTION ROD VALUES BY HEMISPHERE: 
A MANOV A was conducted to assess vehicle injection ROD values with respect 
to the independent variables of treatment hemisphere and group. No significant 
differences were found to exist between vehicle injection ROD samples collected from left 
or right hemispheres.(F(3,23) = 1.60) 
WITHIN GROUP ANALYSIS: 
A student paired t-test was conducted on QNB injection ROD scores versus 
vehicle injection ROD scores of each group to determine if a difference existed betweep 
the two means. No significant difference was found between the QNB and vehicle 
• 
injection samples of the one day group (t = .89). Within the four day survival group of 
experiment one, a significant difference was found to exist between QNB injection and 
vehicle injection ROD samples (t = 2.90 , p = .018). Within the four day group of 
experiment two, the mean ROD values of the QNB and vehicle injection scores were 
found to be significantly different (t = 9.98 , p = .002). The QNB and vehicle injection 
ROD mean values were not found to be significantly different within the 14 day survival 
group (t = . 89). The 21 day survival group mean ROD values were not found to be 
significantly different between the QNB and vehicle injection samples (t = 1.31). 
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DISCUSSION. 
The results of the present study support the hypothesis that prolonged muscarinic 
receptor antagonism by QNB is a sufficient stimulus for the elicitation of AChE positive 
fiber outgrowth near sites of injection in rat hippocampi. 
Time course: 
The time course for the occurrence of AChE positive staining increases m 
experiment one was determined by sacrificing animals at one, four, 14 or 21 days after 
treatment with QNB. Evidence of sprouting was observed at four and 14 days but not 
at one or 21 days following treatment. The observed AChE stain increases were 
demonstrated more often in the four day group (68 percent of subjects) while a less 
frequent AChE positive increase could be seen in 14 day animals (33.3 percent of 
subjects). The length (anterior to posterior plane) of the AChE positive stain increases 
through hippocampal tissue was greatest in the four day versus the 14 day subjects and 
the mean density of AChE stain increases were greater in four than 14 day subjects 
although this difference was non significant. 
There is no literature addressing the time course of antagonist induced sprouting 
in the CNS. However, the optimal sprouting time of four days described in the present 
study is within the time frame of sprouting responses seen in other hippocampal sprouting 
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paradigms. It has been suggested that the initiation of sprouting within the CNS requires 
one to five days in the adult (Cotman et al., 1984; Gage et al., 1983). Two to four days 
following electrolytic lesion of the perforant path, Benowitz et al., (1990) observed an 
increase in growth associated phosphoprotein (GAP-43) levels within the molecular layer 
of the dentate gyrus. Growth associated phosphoprotein is a marker of regenerating 
axons and is used to label sprouting processes. One week following a selective lesion of 
the hippocampal granule cells, McKeon et al., (1989) observed a marked increase in 
AChE staining in the molecular layer adjacent to the lesioned granule cells. Storm-
Mathisen (1974) measured AChE levels in the hippocampus following a unilateral lesion 
of the entorhinal cortex input into the dentate gyrus and reported that AChE positive stain 
intensification in the molecular layer was fully developed by eight days following 
transection of the perforant path in adult rats. Storm-Mathisen (1974) did not however, 
see stain increases at two or four days post lesion. These authors sampled animals at 
two, four and eight days after a perforant path lesion. This suggests that sprouting within 
the molecular layer of the DG occurs between four and eight days after a lesion of the 
perforant path. This time frame for sprouting initiation is in line with findings of the 
present study utilizing a muscarinic antagonist stimulus. 
Cotman and Nieto-Sampedro (1984) suggest that unilateral entorhinal cortex 
lesions evoke synaptic growth over several weeks and its rate is contingent on the rate of 
clearance of degenerating synapses. One day after a unilateral lesion of the entorhinal 
cortex, 90 percent of the synapses in the outer molecular layer are lost. Three days 
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following the lesion, a massive regrowth of residual fiber systems in the dentate gyrus 
occurs (Cotman et al., 1984). This time frame for outgrowth initiation is consistent with 
that seen in the present study. It is unlikely that the sprouting observed in the present 
paradigm involved terminal degeneration prior to sprouting. The visualization of 
ultrastructural features of synapses in sprouting zones via electron microscopy would help 
address this question. 
In the periphery, researchers have utilized a paradigm similar to that of the present 
study to elicit sprouting at the muscle endplate of the mouse. Holland et al. (1980) 
antagonized nicotinic receptors at the neuromuscular junction using the irreversible 
antagonist alpha-bungarotoxin. Sprouting of presynaptic terminals into the antagonized 
end plate was observed by four to eight days after injections with the antagonist. The time 
course of peripheral antagonist induced sprouting appears to parallel that of central. 
antagonist induced sprouting displayed in the present study. 
While AChE positive growth was observed at both four and 14 days in the presen t 
study, it was clearly absent at one and 21 days post treatment. The 1 day subjects 
demonstrated an increased darkening along the length of injection tracks. However, th is 
is not attributed to a drug induced sprouting of AChE positive fibers but rather to blood 
accumulation in that region following surgery just 24 hours prior. This pattern of 
darkening is characteristic of one day animals and did not extend beyond the boundary 
of the injection track created by the injection cannula. This restricted darkening within 
the cavity formed by the cannula is support for the idea that one day darkening is not due 
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to sprouting. Stain increases seen within four day subjects regularly extended into tissue 
outside the injection track. If the increased darkening of one day subjects was due to 
sprouting it would be expected to have occurred with the same intensity beyond the 
cannula track into surrounding tissue as seen in four day subjects. Further, this increased 
darkening along the track was evident in both control and QNB injected hemispheres. 
The absence of a sprouting response by 21 days post surgery is a consisten t 
finding of the present study. This can most adequately be explained in context of the 
finite nature of the stimulus used. In the lesion induced sprouting paradigm, increased 
AChE can be demonstrated for months following the initiation of sprouting (Lynch et al . , 
1972 ; Storm-Mathisen, 1974; Woodruff and Baisden, 1989). In the case of unilateral 
entorhinal cortex lesions, the loss of entorhinal terminals in the molecular layer initiates 
the reinnervation of degenerated terminal spaces by adjacent septal terminal fields in the 
molecular layer (Cotman et al., 1984). These newly formed fields of innervation may 
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persist due to persistence of the stimulus (loss of afferents from the entorhinal cortex or 
perforant path). In the present study however, the duration of QNB antagonism is finite 
given the ongoing process of receptor turnover. Once the life span of a receptor is 
surpassed it is replaced by another receptor of the same type. This new receptor will not 
be the source of an antagonist induced signal because QNB will not be present to bind to 
it. Quinuclidinyl benzilate binds to existing receptor populations upon its initial injection 
into the hippocampus and presumably any excess QNB will eventually be removed from 
the extracellular space and transported to peripheral organs in the circulatory system 
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where it is excreted from the body. Therefore, only receptors present at the time of 
injection will bind QNB and the length of the receptor/QNB association is dependent on 
receptor mortality. In the introduction, it was suggested that muscarinic receptors 
turnover every six days (Sethy et al., 1990). Given this, the antagonism of receptors by 
QNB could persist at most six days before new non-QNB bound receptors would develop 
and restore normal receptor functioning and effectively remove or "turn off' the proposed 
stimulus for growth. Acetylcholinesterase positive increases observed at 14 days 
following QNB treatment may in fact be due to residual terminal outgrowth formed 
between the period of one and six days during which time the sprouting stimulus was 
present. By 14 days, the percentage of subjects demonstrating an AChE positive increase 
has decreased considerably from the four day group percentage. It is possible that once 
the stimulus for sprouting is "turned off", retraction of sprouted fibers occurs. This 
seems likely given that this novel technique elicits sprouting in the undamaged 
hippocampal system of adults in which circuitry is presumably fully developed and 
functional. In this environment, sprouted fibers would have no utility in a stimulus "turn 
off" state given the existing functional connections, and would presumably retract. 
Variability: 
As discussed in the introduction, there are a number of studies which attempted 
to show that a blockade of postsynaptic nicotinic receptors will induce sprouting of 
presynaptic terminals in the PNS (Pestronk et al., 1978 ; Tonge, 1978). These 
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investigations did not support the idea that postsynaptic antagonism would induce terminal 
sprouting. The study of Holland et al. (1980) was the first to demonstrate that prolonged 
antagonism of postsynaptic nicotinic receptors induces sprouting at the muscle endplate 
in mice. The results of the present study are relatively robust while at the same time 
tending to be somewhat variable with respect to the magnitude of the AChE positive 
response observed between animals. Variability of the sprouting responses observed , 
while frustrating, is not terribly upsetting given the difficulty researchers had producing 
the effect in the PNS, an area traditionally attributed with greater plastic potential than 
the CNS (Oorschot and Jones, 1990 ; Gage et al., 1983). 
There are a number of explanations for the variability seen. One source of 
variability could revolve around the drug preparation. When QNB was mixed with the 
vehicle beta hydroxipropylcyclodextrin, the former was not entirely dissolved in the latter; 
Sonication of the mixture led to as much of the drug going into solution as was possible . 
. 
However, the drug/vehicle combination resembled a suspension which was somewhat 
viscous in texture. These characteristics may have led to varying doses for different 
injections given that it is difficult to control the exact dosage of QNB if it is both in 
suspension and solution in the same preparation. The viscous characteristic of the 
drug/vehicle combination may have also contributed to an injection spread in the 
hippocampus that was less than concentric or spherical. Consequently, the size of the 
area of drug action may have varied from animal to animal as was seen. To understand 
exactly how much the drug preparation affected drug spread within hippocampal tissue, 
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the physics of the drug spread would have to be directly evaluated. To investigate how 
the QNB/vehicle combination operated in hippocampal tissue a radiolabelled batch of 
QNB could be injected and the subsequent spread measured using autoradiographic 
imaging techniques and compared with the AChE reaction. 
Area of injection versus receptor densities: 
The area of the hippocampus into which the QNB was injected may well 
contribute to the presence or absence of an AChE positive response. Of the four day 
subjects in experiment one, 15 distinct areas of increase were observed. Eleven of these 
were found in the DG molecular, hilar or granule layers while four were observed in area 
CA 1 (strata oriens, pyramidale and superficial radiatum only). All these areas are 
characteristically abundant in muscarinic receptors and AChE containing fibers. One 
exception which will be discussed later is the granule cell layer which exhibited AChE 
positive staining increases yet is low in muscarinic receptors and AChE levels (Swanson 
et al., 1987). The extension of AChE staining into only superficial CA 1 stratum radiatum 
could be due to the low levels of AChE positive fibers in this region (Swanson et al. , 
1987). Also, below stratum radiatum there are low levels of muscarinic receptors that 
could bind QNB (Swanson et al., 1987). All other regions showing stain increases are 
rich in AChE positive fibers and muscarinic receptors. 
Two injections in SLM and one each in CA3 and DG did not demonstrate AChE 
increases in experiment one. The one case of an AChE devoid DG injected region is not 
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readily explicable given the eleven incidences of increase in this region. The 
nonresponsive CA3 injection too is also surprising given the presence of muscarinic 
receptors and AChE in this region. Perhaps these findings are the result of variation in 
the injection routine in these cases. Alternatively, in the case of the CA3 injection of 
QNB, it is possible that normally high baseline AChE positive staining in this region 
masked the effect of injecting QNB into that area such that any "new" increases were 
undetectable against the background. This is supported by the fact that no CA3 stain 
increases were observed in any case. 
Of the four day subjects in experiment two that demonstrated an AChE positive 
stain increase, six distinct areas of increase were recorded. Two were seen in DG 
molecular, hilar or granule layers while four increases were observed in CAl strata 
oriens, pyramidale and superficial radiatum only. Again, these sites of stain increase ~t 
with known muscarinic receptor and AChE distributions except in the case of an increase 
extending into the granule cell layer. The case of an AChE devoid injection into the DG 
of an experiment two subject cannot be explained given this regions ability to support 
antagonist induced increases in AChE staining. Injection variability in this case may be 
to blame. 
Fourteen day survival subjects of experiment one demonstrated AChE positi\ e 
increases in CAl, DG (molecular, hilar and granule layers) and, in one case, the cortex 
while revealing no response to injections into SLM and in five cases area CAl (oriens 
and pyramidale). The AChE devoid CA 1 injection areas in the 14 day subjects may 
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simply have resulted from the cessation of the QNB induced trophic signal by this time, 
as discussed above, or alternatively, injection variability. 
Overall, injections into the molecular layer and hilus of DG in four and 14 day 
subjects appear to consistently demonstrate an AChE positive fiber increase. This is most 
probably due to the high density of muscarinic receptors in these regions for QNB to act 
upon (Swanson et al., 1987). Areas of CA 1 exhibiting high to moderate muscarinic 
receptor densities are strata oriens, pyramidale and radiatum. These regions of CA 1 all 
exhibited the ability to support AChE stain increases in response to QNB antagonism with 
the partial exception of stratum radiatum that exhibited increases in AChE superficially 
as though arising from sprouting AChE containing fibers in strata oriens or pyramidale. 
One area receiving a QNB injection that never exhibited an increase in staining was SLM. 
This finding fits well with what is known of muscarinic receptor densities within thi~ 
area. Stratum moleculare or SLM contains no muscarinic receptors and few AChE 
positive fibers (Swanson et al., 1987). 
Source of AChE positive fiber sprouting: 
In the present study it is possible that the septal cholinergic projection to the 
hippocampus is the source of AChE positive fiber increases observed. To test this 
hypothesis the same paradigm should be repeated in conjunction with septal lesions. If 
the QNB induced sprouting is from septal fibers, then the QNB treatment should not 
produce an increase in AChE fiber outgrowth in a septal lesion condition. 
96 
The hippocampus has been shown to contain numerous AChE positi \ e 
interneurons (Swanson et al., 1987). It may be that AChE positive intemeurons in the 
hippocampus are the source of the AChE positive outgrowth seen (Swanson et al., 1987) . 
These interneurons may be characterized by a transmitter other than Ach and yet be 
AChE positive. These interneurons are found throughout the hippocampus, however 
mainly in the hilus (McKeon et al., 1989). Given that they are predominantly found in 
the hilus, it is plausible that these intemeurons are the source of AChE positive fiber 
outgrowth in that region reported in the present study. McKeon et al., ( 1989) lesioned 
granule cells of the DG and reported AChE positive but non-cholinergic sprouting into 
the molecular layer. Septal lesions in combination with granule cell lesions did not deter 
the occurrence of AChE positive sprouting (McKeon et al., 1989). McKeon et al. , 
(1989) concluded that the source of AChE positive sprouting seen in their study is mo~t 
probably AChE containing intemeurons of the hippocampus. 
Source of the trophic signal: 
In the present study it is believed that the signal initiating AChE positive fiber 
outgrowth arose from the antagonized muscarinic receptor complex. The staining 
distributions tend to fit well with known localizations of muscarinic receptors in the 
hippocampus (Swanson et al., 1987). Given that the majority of muscarinic receptors in 
the hippocampus are postsynaptic (M 1) in nature (Zilles, 1988), the trophic signal 1s 
believed to be in the post to presynaptic direction and the trigger of postsynaptically 
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directed growth of presynaptic terminals. 
The presence of presynaptic receptors (thought to be M2 receptors) that would 
have been antagonized by QNB (as well as antagonizing the more abundant postsynaptic 
receptors) necessitates a discussion of presynaptic influences. Presynaptic muscarinic.; 
receptors are not thought to have played a role in the sprouting response seen in the 
present study as they are attributed with controlling Ach release from presynaptic 
terminals (Cooper, Bloom and Roth, 1986 ; Sokolovsky, 1984 ; North et al., 1985). 
Muscarinic antagonists have been found to increase Ach release by acting at presynaptic 
receptor sites while muscarinic agonists bound presynaptically have been shown to 
decrease Ach release in the hippocampus (Sethy et al., 1990 ; Cooper et al., 1986 ; 
Sokolovsky, 1984). Given that QNB antagonism increases Ach release when bound 
presynaptically (Sethy et al., 1990), the presynaptic muscarinic receptor can be implicated 
in facilitating sprouting only if Ach increases contribute to sprouting responses. Lipton , 
Frosch, Phillips, Tauck and Aizenman (1988) investigated the effects of Ach on neurite 
outgrowth in postnatal rat retinal ganglion cell cultures. These researchers reported that 
nicotinic antagonism of ganglion cells in culture initiates increases in process outgrowth 
within 24 hours of application. Normally, cells in retinal ganglion cell culture leak Ach 
(Lipton et al., 1988). Under such conditions neurite outgrowth is inhibited. Lipton et 
al. (1988) concluded that nicotinic antagonism elicits growth by removing the inhibitory 
effect of tonic levels of Ach in the culture. Lipton et al. (1988) suggest that in the retina, 
Ach inhibits growth processes. If the same is true for the hippocampus of adult rats then 
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antagonism of presynaptic receptors with QNB, which increases Ach release (Sethy et al., 
1990; Sokolovsky, 1984; Cooper et al., 1986), may actually hinder growth. It is more 
plausible that postsynaptic signals subsequent to QNB antagonism of muscarinic receptors 
initiated AChE positive fiber outgrowth seen in the present study. 
In the introduction, it was stated that M 1 and M2 receptor populations occur with 
varying densities in different regions of the hippocampus (Zilles, 1988). The sites of 
consistent AChE positive fiber sprouting in the present study (molecular layer of the DG 
; strata oriens of CA 1) are more heavily populated with M1 receptors then with M2 
receptors (Zilles, 1988). One exception is stratum pyramidale of area CA 1. This area 
showed AChE positive stain increases and is abundant in M2 receptors (Zilles, 1988). 
The most robust AChE positive fiber sprouting of the present study was found in the 
molecular layer of the DG, an area with low densities of M2 receptors and high densitie~ 
of M 1 receptors (Zilles, 1988). From this it would appear that the most likely candidate 
for mediation of QNB induced trophic signals are M 1 receptors. 
In the PNS, blockade of nicotinic receptors was found to induce sprouting at the 
muscle endplate of mice (Holland et al., 1980). It may be, as presumed in the present 
study, that trophic signals originated from antagonized postsynaptic receptors. However . 
one alternative explanation is that sprouting was induced by muscle inactivity (Holland 
et al., 1980). In the state of prolonged nicotinic receptor blockade at the neuromuscular 
junction the postsynaptic muscle fibers are inactive due to the inability of Ach to bind to 
postsynaptic receptors. It may be that muscle inactivity led to the production of trophic 
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signals that induced sprouting at the endplate. In the present study this explanation is not 
possible given that there are numerous non-muscarinic receptors on postsynaptic surfaces 
which will continue to respond to neurotransmitter activation during muscarinic 
antagonism in the hippocampus. Trophic signal production in the present study must have 
arisen from a source other than postsynaptic inactivity. 
Specificity of AChE positive fiber reinnervation: 
The question arises as to the specificity of the AChE fiber growth with respect 
to sites of reinnervation. For the most part, areas exhibiting sprouting responses contain 
muscarinic receptors, the proposed source of trophic signals in the present study 
(Swanson et al., 1987). Therefore, it may be that the AChE positive fiber increases seen 
terminated at antagonized sites as guided by a signal consequent to muscarinic recepto( 
antagonism. In this case, it is suggested that a trophic signal is generated by the 
QNB/muscarinic receptor interaction and that this interaction also acts to guide fiber 
outgrowth to sites of antagonized receptors as opposed to merely signalling a generalized 
growth of AChE positive fibers toward no specific target. 
Alternatively, AChE containing fibers may have grown to non-antagonized sites 
also, presumably due to a generalized release of some trophic factor in the absence of 
specific guidance (such as from antagonized targets). In this case, the QNB antagonism 
of muscarinic receptors induces a trophic response but does not guide the sprouting fibers 
Both possibilities may in fact be consequent to prolonged QNB antagonism of muscarinic 
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receptors in the hippocampus. One instance of support for the hypothesis that non-
specific or non-guided sprouting of adjacent fibers is actually occurring may be the 
sprouting observed in the molecular layer of the DG. In some cases, AChE fibe r 
increases could be seen in an area normally devoid of AChE and containing few 
muscarinic receptors: the granule cell layer. In control AChE stained preparations, the 
granule cell layer appears as a white band between the moleculare and hilar regions. In 
some QNB treated cases, clear increases in staining were seen in this region presumably 
arising from adjacent areas rich in endogenous AChE containing fibers (see figures 5, 8 
and 14). Because the granule layer contains few muscarinic receptors for QNB to have 
bound to, it is not likely that signals conducive to sprouting into this region arose from 
the granule layer itself. It is possible that the sprouting response to a trophic signal 
consequent to QNB binding to muscarinic receptors is general in nature and nor 
specifically directed towards sites of QNB antagonism. This could conceivably be 
accomplished through a general or diffuse release of some trophic factor during QNB 
antagonism of muscarinic receptors. Alternatively, the AChE fiber increases evident in 
the granule layer of some subjects may well terminate at antagonized sites. To establish 
whether QNB antagonism guides sprouting as well as initiating it, techniques that allow 
the dual visualization of QNB binding sites and sprouted terminals would be required. 
In this way, it could be determined if there is a strong correlation between QNB binding 
sites and AChE positive sprouted terminals. 
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Alternative explanations: 
The hypothesis behind the present study was that QNB antagonism of hippocampal 
muscarinic receptors induces AChE positive fiber increases as a result of sprouting 
cholinergic fibers. A systematic review of the possible alternative explanations would 
help clarify and strengthen the results that tend to support this hypothesis. 
One obvious alternative explanation for the AChE positive fiber increases would 
be that mechanical damage from the injection of QNB into the hippocampus caused the 
sprouting observed. Perhaps the force of the injections were such that cell damage in the 
hippocampus resulted in the sprouting response observed. The injection then would 
effectively act as a lesion. This possibility was controlled for however by 1.) a careful 
injection routine and 2.) the use of within animal controls. The QNB and vehicle were 
injected slowly over a four minute period. If the injection procedure caused damag~ 
induced sprouting in experimental hemispheres, then the same should have been seen in 
control hemispheres - it was not. 
The increased AChE staining seen at four and 14 days after QNB treatment are 
hypothesized to be the result of sprouting cholinergic fibers. One alternative explanation 
is that the AChE positive fiber increases were due to an increase in glial and macrophage 
responsiveness in the region of the injection. This is unlikely given that the present study 
employed an inhibitor of non-specific esterases (ethopropazine) in the AChE stain 
procedure to rule out the occurrence of esterases associated with glial responses (McKeon 
et al., 1989). Further, if esterase-producing glial responses occurred in the QNB injected 
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hemispheres they would have been expected to occur with similar frequency in control 
hemispheres - they did not. 
Hemisphere and sex differences: 
Experiment two investigated the variables of sex and hemisphere in the QNB 
induced sprouting response. The results suggest that the response to QNB blockade is 
not contingent on the hemisphere of treatment. Quinuclidinyl benzilate induced AChE 
positive stain increases were observed in both left and right hemispheres. 
The occurrence of AChE positive fiber sprouting also did not appear to be 
contingent on sex. The results of experiment one showed that female Sprague Dawley 
rats could exhibit an increase in AChE staining in response to QNB antagonism. 
Experiment two demonstrated that males too could support AChE fiber sprouting i11 
response to QNB. Within the scope of this study, sex differences do not seem to exist 
with respect to the ability of animals to demonstrate sprouting responses to QNB 
antagonism. Future research utilizing the paradigm of the present study could investigate 
whether other strains of rats and even other species of animals are equally capable of 
exhibiting sprouting under similar treatment conditions. 
Effect of ONB concentration: 
Experiment two also looked at varying levels of QNB concentration with respect 
to AChE positive fiber outgrowth. Varying the QNB dose between 20 ~g or 40 ~g was 
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not a determining factor for the occurrence of AChE positive fiber outgrowth in the 
present study. Sprouting was observed equally under the two drug conditions in both 
male and female rats. It may be that AChE positive sprouting will occur when an 
unknown proportion of receptors in a given area are antagonized and that both drug doses 
satisfy this demand. The proportion of receptor antagonism then would presumably be 
directly related to trophic factor activation. To assess whether sprouting is contingent on 
levels of receptor binding, tissue culture techniques would be beneficial. A coculture of 
muscarinic-rich hippocampal cells and septal cholinergic cells could be treated with 
radiolabelled QNB and subsequent muscarinic binding/cholinergic sprouting correlated. 
Mediation of muscarinic antagonist induced sprouting: 
It has been shown that NGF exists in highest CNS concentration m the 
hippocampus (Collins and Crutcher, 1985). Entorhinal cortex destruction has been shown 
to result in reactive synaptogenesis characterized by sprouting of cholinergic fibers from 
the inner one third of the molecular layer filling the deafferented outer molecular layer 
(Lynch et al. , 1972 ; Stan field and Cowan, 1982 ; Woodruff et al. , 1990 ; McKeon et 
al., 1989). Crutcher (1987) has demonstrated that NGF-like activity is increased in the 
fascia dentata of the rat following perforant path (PP) lesions. It is likely that the 
sprouting of cholinergic fibers observed following entorhinal cortex lesions is dependent 
on NGF (Gage, Buzsaki and Armstrong, 1990). The present study demonstrated an 
AChE positive stain increase that indicated the occurrence of cholinergic fiber sprouting 
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in tissues receiving injections of QNB. The trophic factor(s) mediating this response can 
not be determined based on the present study. However, given the implication of NGF 
in other forms of hippocampal sprouting it is plausible that this trophic agent is mediating 
sprouting in the present paradigm as well. Crutcher et al., (1982) have shown that NGF 
concentrations in the hippocampus are elevated following fimbria-fornix lesions. Given 
that prolonged QNB exposure to hippocampal tissue may mimic this denervated state it 
is possible that QNB antagonism too could increase NGF concentrations. 
Gage et al. (1988) have found that glial cells may mediate NGF activity in the 
hippocampus. Fimbria-fornix and PP lesions separately induce increases in glial fibrillary 
acidic protein immunoreactivity (GFAP-IR). It has been suggested that this increase in 
GFAP-IR is reflective of astrocytic cell activation and is a necessary requirement for the 
occurrence of sprouting (Gage et al., 1988). Given the implication of glial cell activity 
. 
in sprouting responses, it is possible that increases in astrocyte activation would 
accompany the sprouting response observed in the present study (Gage et al., 1988): 
Future research into this question with respect to the present paradigm should involve 
immunoreacting antagonist treated tissue for both NGF and GFAP to determine if NGF 
and astrocyte activation are increased during QNB induced sprouting. 
Markers of sprouting hippocampal cholinergic fibers: 
Acetylcholinesterase has been used as an indicator of growth of cholinergic fibers 
in numerous studies including the present experiments (Lynch et al., 1972 ; Storm-
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Mathisen, 1974; Dunnett et al., 1982; Dunnett et al., 1986; Stanfield et al., 1982; 
Bjorklund et al., 1983 ; McKeon et al., 1989). While AChE is not a direct indicator of 
cholinergic neurons, it correlates well with ChAT activity, a direct marker of Ach 
synthesizing neurons (Swanson et al., 1987). In future, investigations of muscarinic 
antagonist induced cholinergic sprouting could involve reacting tissue for both AChE and 
ChAT and in this way compare the usefulness of both markers in assessing cholinergic 
fiber outgrowth within the framework of the present paradigm. 
The above mentioned means of evaluating sprouting cholinergic fibers via 
biochemical markers are invaluable techniques for assessing changes in the cholinergic 
fiber system. Another approach to evaluating the proliferation of fiber systems involves 
reacting treated tissue for markers of axonal outgrowth and regeneration. Growth 
associated phosphoprotein (GAP-43), also known as B-50, is expressed by neurons durin~ 
states of axonal outgrowth (Benowitz et al., 1990). Growth associated phosphoprotei n 
is transported to distal segments of developing axons and can be labelled via 
immunocytochemical techniques (Goslin, Schreyer, Skene and Banker, 1988). Growth 
associated phosphoprotein would be a useful marker in future studies evaluating synaptic 
changes subsequent to prolonged muscarinic antagonism. Used in association with 
biochemical markers of cholinergic activity, GAP-43 could add useful insight into the 
time course and magnitude of structural changes in neurons during growth conditions and 
could determine if more than cholinergic fibers are sprouting in response to that stimulus. 
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Practical application of antagonist induced sprouting: 
Prolonged muscarinic antagonist induced sprouting in the CNS as illustrated in the 
present experiments is a novel approach to understanding CNS plastic changes. Once the 
mechanisms underlying the sprouting responses observed are elucidated, this technique 
could conceivably be employed towards some therapeutic ends. Cholinergic 
transplantation paradigms in which embryonic septal tissue is implanted into the 
deafferented hippocampus of rats could conceivably benefit from antagonist induced 
sprouting. One of the negative aspects of tissue grafts with respect to therapeutic 
application is that they exhibit an upper limit with respect to the amount of reinnervation 
attained. Cholinergic cell transplants into the damaged hippocampus attain maximal 
reinnervation of the target by approximately six months (Bjorklund et al., 1983 ; Dunnett 
et al., 1986). When used in combination with muscarinic antagonism, cholinergi~ 
grafting techniques may display more enduring growth past the usual upper limit . 
Presumably, once transplanted cells extend their axons into the denervated tissue, any 
trophic signal generated by the loss of normal innervation ceases. Muscarinic antagonism 
in the hippocampus could maintain a growth inducing signal that could allow transplanted 
fibers to extend further into that structure. This could be achieved by infusing a 
muscarinic antagonist into the hippocampus following graft implantation and assessing the 
extent of outgrowth relative to controls infused with vehicle only. 
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